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Abstract of the Dissertation 
 
Device Engineering for Infectious Disease Diagnosis using Isothermal 
DNA Amplification and Lateral Flow Detection 
 
By 
 
Kristina Roskos 
 
Keck Graduate Institute of Applied Life Sciences: 2013 
 
Technologies that enable infectious diseases diagnosis in low-resource settings 
could greatly facilitate effective treatment and containment of such diseases. Nucleic acid 
amplification testing can be used to identify pathogens, but typically requires highly-
trained personnel and large, expensive lab equipment, neither of which is available in 
low-resource settings. Our overall goal is to develop a portable diagnostic system that 
utilizes a low-cost, disposable, mesofluidic cartridge and a handheld electronics unit to 
perform fully-integrated nucleic acid testing at the point of care in low-resource settings. 
As a first step toward this goal, we developed a subunit to execute isothermal nucleic acid 
amplification coupled with lateral flow detection, in parallel with the development of a 
sample preparation subunit by our collaborators at Claremont BioSolutions. Fluid 
handling inside the amplification and detection cartridge is facilitated through one-way 
passive valves, flexible pouches, and electrolysis-driven pumps, which promotes a 
compact and inexpensive instrument design. The closed-system disposable prevents 
 workspace amplicon contamination. The cartridge design is based on standard, scalable 
manufacturing techniques, such as injection molding. Using an initial prototype system, 
we demonstrated detection of purified Mycobacterium tuberculosis genomic DNA. We 
then developed a refined amplification and detection cartridge in conjunction with an 
improved portable instrument, which automates pumping, heating, and timing, using a 
design format compatible with eventual integration with the sample preparation subunit. 
This refined cartridge incorporates a novel, inexpensive, stand-alone, passive valve, 
smaller, integrated pump components, a more complex injection molded polycarbonate 
cartridge core piece, and enhanced lateral flow chambers to improve visual detection. The 
independent valve component can be tailored for a variety of fluidic systems. We 
demonstrated appropriate fluidic and thermal control, and successful isothermal nucleic 
acid amplification within this refined amplification and detection subunit. We have 
developed a separate fluidic module for master-mix reagent storage and reconstitution 
that is designed to act as the interface between the amplification and detection subunit 
and the upstream sample preparation subunit. We envision that the merger of these two 
subunits into a fully-integrated cartridge will enable user-friendly, automated sample-in 
to answer-out diagnosis of infectious diseases in primary care settings of low-resource 
countries with high disease burden.  
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TABLE OF FIGURES 
Figure 1: Schematic drawing illustrating system operating principle during process 
execution. Sample is loaded and pushed through a miniaturized bead blender 
(“Omnivalve”), lysing mycobacteria and eluting DNA into downstream chambers where 
it reconstitutes lyophilized amplification master-mix materials. The master-mix is then 
heated, allowing isothermal amplification to occur, and the fluid is then pumped onto 
lateral flow strips where amplified product can be visually detected by the user. 
Figure 2: Conceptual drawing of system components. (a) Cartridge viewed from the top, 
showing the access ports to the reaction and pump pouches on the underside of the 
cartridge (indicated in gray outline), and the position of lateral flow strips in anti-parallel 
orientation. (b) Cartridge viewed from the bottom, showing the reaction pouches with 
overlaid pump pouches. (c) and (d) Side view of the cartridge on the heater (not to scale), 
illustrating the operating principle. (c) Master-mix is injected through the septum inlet 
into the reaction pouch, and targeted DNA sequences are isothermally amplified on top of 
the temperature-controlled heater surface. (d) Applying current to the electrolytic pump 
pushes fluid into the pump pouch. The pump pouch expands, thereby compressing the 
reaction pouch up against the dome-shaped recess in the cartridge, which forces fluid out 
of the reaction pouch through the one-way check valve and into the lateral flow strip 
pouch. 
Figure 3: Cartridge and instrument. (a) Underside of cartridge, showing two reaction 
pouches sealed inside two pump pouches on the bottom surface of the bottom card. (b) 
Top side of cartridge: lateral flow strips are sealed inside the grooves forming the lateral 
flow strip pouches, and electrolytic chambers are press-fit in place. Not shown: silicone 
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foam is placed between the cards, and pump chambers are filled with electrolyte solution 
to complete the assembly. (c) Small portable prototype heater, which contains the control 
electronics, thin-film polyimide heater, an aluminum heater surface, and thermal 
insulation below the heater and around the perimeter of the area where the cartridge is 
inserted. (d) Heater with a cartridge secured in place (grey lid), prior to test execution. (b) 
and (d) The red line on the NALF strips represents the dry reagent formulation with 
colored microspheres dispensed on the conjugate pad. 
Figure 4: Conceptual depictions of EXPAR reactions and coupling the amplification 
products with NALF. (a) First-stage EXPAR, where Trigger X primes and is extended 
along a template provided in the EXPAR master-mix. (b) Second-stage EXPAR 
illustrating Trigger X converting to a reporter oligonucleotide (Reporter Y). (c) NALF 
coupled to second-stage EXPAR, where the Reporter Y oligonucleotide binds DNA-
functionalized microspheres and DNA hybridized on the nitrocellulose at the test line, 
resulting in a visible test line. This binding is dependent on the presence of Reporter Y, 
so the test line will only be present in positive samples. Additional DNA functionalized 
on the microspheres will bind DNA hybridized on the nitrocellulose at the control line, 
resulting in a visible line. The binding at the control line is independent of the presence of 
Reporter Y, and, therefore, acts as an indicator of proper lateral flow function. 
Figure 5: (a) Measured temperature of the fluid inside the reaction pouch of a cartridge 
attached to the heater as a function of time. Filling the pump pouch with liquid improves 
the thermal transfer from the heater to the reaction fluid, which reaches a stable 
temperature of 62±0.1 °C within approximately ten minutes. Thermal paste applied 
between the heater surface and pump pouch provides no further improvements. (b) and (c) 
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Thermal simulations (COMSOL Multiphysics) of the cartridge on top of the heater, 
showing horizontal cross-sections within the center of the reaction fluid layer of the 
cartridge. (b) Uniform heating to the desired temperature (63 °C) is observed using a 
model with ideal thermal contact between cartridge and heater, with no air gap. (c) 
Introducing a 150 µm thick thermally-resistive layer between cartridge and heater leads 
to a lower temperature and less uniform heating within the reaction pouch. The cross-
hatches in the middle of the pump pouches indicate the dimensions of the circular 
reaction pouches. An air bubble was intentionally introduced into the outlet port of the 
reaction chamber to simulate air trapped in the reaction pouches after fluid is inserted. 
Figure 6: Conceptual depiction of NALF detection coupled to LAMP. (a) Amplified 
master-mix applied to the conjugate pad enables amplicons to interact with colored 
polystyrene microspheres functionalized with appropriate capture moieties. (b) After 
migrating along the nitrocellulose membrane, microspheres carrying amplicons are 
captured at the test line. (c) At the control line, microspheres are captured irrespective of 
the presence of amplicon. 
Figure 7: Amplification results. (a) LAMP based detection of M.tb genomic DNA 
performed in the cartridge on the instrument: NALF strips of two representative 
cartridges, after 10 minutes of isothermal amplification, followed by 10 min for lateral 
flow detection. (b) LAMP master-mix amplified in the cartridge on the heater, analyzed 
via gel electrophoresis (Lanes 1 and 2), compared to amplification performed in reaction 
tubes on a standard heat block (Lanes 3 and 4). Lane 5: DNA molecular weight markers. 
For (a) and (b), positive (+) reactions show LAMP product starting from 3000 copies of 
M.tb DNA, and negative (-) reactions show no product since no M.tb DNA was added to 
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the reaction. (c) EXPAR based detection of M.tb genomic DNA performed in the 
cartridge on the instrument: NALF strips of two representative cartridges, after 60 
minutes of isothermal amplification, followed by 10 min for lateral flow detection. 
Positive (+) reactions contained 6x10
5
 copies M.tb DNA, and negative (-) reactions 
contained no M.tb DNA. 
Figure 8: Valve design components: (a) inner rigid core with one end capped and one 
side port; (b) rigid core with elastomeric sleeve covering side port; (c) encapsulated valve 
for in-line use. 
Figure 9: Different embodiments of the sleeve valve. (a) Stainless steel core tubing with 
silicone tubing sleeve. (b) PEEK core tubing with cast silicone sleeves, with varying 
sleeve inner diameters, as indicated in the figure. 
Figure 10: Cracking and sustained open pressure for different valve embodiments. (a) 
Pressure as a function of time for an example steel valve, indicating (i) cracking pressure 
and (ii) sustained open pressure; (b) Cracking pressure for the two stainless steel valve 
sets; (c) Cracking pressure for PEEK valve sets 1-5, as a function of silicone sleeve inner 
diameter 
Figure 11: Nucleic acid amplification reactions with (solid lines) and without (dashed 
lines) autoclaved valve materials incubated in the reaction buffer prior to running the 
amplification reaction. The valve materials do not inhibit the reaction. A small piece of 
each valve material, either autoclaved or in its original form, was incubated in LAMP 
reaction buffer for 60 minutes at 63 °C, with agitation. We then used this buffer solution 
in setting up LAMP reactions that were subsequently amplified in the presence and 
absence of the targeted genomic DNA by incubation at 63 °C, with real time fluorescence 
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monitoring using an Opticon2 real-time PCR instrument (Bio-rad, Hercules, CA). Blue: 
LAMP positive reactions containing 3000 copies of target genomic DNA per reaction. 
Red: LAMP negative control reactions, which did not contain target DNA. 
Figure 12: (a) Design concept of the fluidic system of the cartridge. (b) CAD design of 
the cartridge components including: (i) cartridge core, (ii) spacer ring, (iii) reaction insert, 
and (iv) bottom casing. (c) Injection molded pieces of the cartridge components. 
Figure 13: Steps of cartridge insertion into the designed instrument including (a) insert 
cartridge datum into locator slots in the instrument housing at an angle and (b) lower the 
cartridge into the slot and release the spring loaded clip to secure the cartridge. 
Figure 14: Fluidic control of reaction pouch filling. Fluid was pumped into the reaction 
pouch at 3 µL/sec for 91 sec, and then the pump was turned off (grey area). The inlet 
pressure was measured upstream of the inlet valve, in-line with the fluid pumping into the 
reaction pouch. The pump pouch pressure was measured as a surrogate to indicate the 
pressure inside the reaction pouch. (a) Inlet pressure increases, then drops, which 
indicates inlet valve cracking. (b) Inlet and pump pouch pressures build as fluid fills the 
reaction pouch. The outlet valve does not allow fluid to flow out of the reaction chamber. 
The small pressure peak presumably indicates dead air trapped in the reaction pouch 
exiting the chamber through the outlet valve. (c) Maximum peak pressure indicates outlet 
cracking pressure and the point at which fluid begins flowing out of the reaction chamber. 
(d) Inlet pumping was stopped, allowing fluid to exit the reaction chamber and pressure 
inside the reaction pouch to equilibrate. 
Figure 15: Pressure measurement in the upstream channel during injection of 150 µL 
reaction buffer from the sample inlet port into the reaction insert. (a) The barrier vents the 
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dead air ahead of the fluid until the fluid fills the upstream channel. No air is injected into 
the reaction pouch. (b) The venting barrier closes as liquid fills the area underneath the 
barrier. Pressure builds in the upstream fluidic channel until the inlet valve opens. (c) The 
fluid is pumped into the reaction pouch through the inlet valve. The channel pressurizes 
due to the pressure exerted by the filled and closed pump pouch. (d) After approximately 
100 µL liquid is injected into the reaction pouch, the gas behind the injected volume is 
vented through the venting barrier and the remainder of the volume is trapped in the 
vented portion. No air is injected into the reaction pouch. 
Figure 16: Lateral flow strip chamber testbed. (a) Empty lateral flow strip chambers, 
showing embedded hydrophobic barriers (blue). (b) Lateral flow strip chambers with 
lateral flow strips sealed by polycarbonate film. The red line on the conjugate pads is the 
lateral flow conjugate that has been dispensed and dried onto the conjugate pad. 
Figure 17: Temperature of the fluid inside the reaction pouch of a cartridge attached to 
the heater as a function of time. The fluid reaches a stable temperature within 
approximately ten minutes. 
Figure 18: Demonstration of fluidic process in cartridge on instrument. (a) Cartridge 
attached to instrument, with reaction buffer (colored blue) injected into storage chamber. 
(b) Instrument LEDs indicate function of heater (red LED) and ePumps (blue LEDs). (c) 
Lateral flow detection of reaction buffer spiked with synthetic DNA product pumped out 
of the reaction pouch onto the lateral flow strips in the cartridge. 
Figure 19: Detection of M.tb genomic DNA through 60 minutes of isothermal LAMP in 
the cartridge on the instrument, verified via gel electrophoresis of amplified master-mix 
removed from the cartridge after the reaction. Amplified product from both reaction 
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pouches (lanes 3 and 4) generated a similar pattern as the positive control reactions 
performed in tubes on a standard heater (lanes 5 and 6), indicating that desired 
amplification had occurred in the cartridge. All positive reactions contained 3000 copies 
M.tb genomic DNA. No products were generated in negative control reactions (lanes 7 
and 8) that did not contain M.tb DNA. Lane 1 contained 1 kb molecular weight ladder 
and lane 2 was empty. 
Figure 20: Lyophilized pellet storage and reconstitution chamber as originally designed. 
(a) Reconstitution of pellet (red arrow) in blue colored water. (b) Depiction of 
reconstitution, illustrating the pellet wicking the initial fluid front to the bottom of conical 
chamber and pumping further downstream, while introducing an air bubble in the fluid 
stream separating the initial fluid front (ii) from the remaining fluid (i). 
Figure 21: Original system overview diagram. Red area highlights the fluidics interface 
between sample preparation and amplification and detection, which needs to store 
stabilized master-mix reagents until they can be reconstituted by purified sample 
preparation eluate and pumped into the reaction pouch chamber. The initial design 
incorporated lyophilization to stabilize the master-mix reagents. 
Figure 22: Fluidic system overview. (a) Top view: purified sample enters the chamber, 
first absorbing into the lyophilized master-mix material matrix, and then filling the 
chamber completely. (b) Side view: after a short incubation period to allow the reagents 
to diffuse, the reconstituted reaction master-mix is pumped through the outlet. 
Figure 23: Investigation of different reconstitution chamber geometries. For each case, 
showing (i) empty chamber, (ii) partially filled chamber, and (iii) chamber after as much 
fluid could be emptied as possible. (a) Ellipse without any structures. (b) Ellipse with 
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structure in front of outlet intended to catch any air trapped in the chamber. (c) Ellipse 
with chevron structures intended to enhance mixing in the chamber. (d) Ellipse with 
cylindrical pillars intended to enhance mixing in the chamber. All structures inhibited 
emptying of the chambers, leaving large dead volumes of unrecoverable fluid in the 
chambers. The empty ellipse shape (a) had the largest fluid recovery. 
Figure 24: Reconstitution chambers with integrated venting barriers. (a) Reconstitution 
chamber with commercially-available hydrophobic barrier integrated into chamber. (b) 
Reconstitution chamber with integrated hydrophobic barrier and microfiber material, 
which had a higher percentage of fluid that could not be recovered from this chamber 
design. (c) Polypropylene-backed PTFE membrane material heat-sealed to an isolated 
venting chamber downstream of the reconstitution chamber. 
Figure 25: Fluidic interface testbed demonstrating the reconstitution of dried food 
coloring. (a) Top side of fluidic interface testbed showing one of the two fluidic module 
testbeds, including the venting chamber (white) and the reconstitution chamber, with 
orange food coloring dried onto the CF1 microfiber material. (b) Reconstitution chamber 
filled and reconstituting the orange food coloring, with fluid beginning to pump through 
the fluid conduit on the underside of the testbed from the reconstitution chamber to the 
venting chamber. (c) Bottom side of fluidic interface testbed, showing polypropylene 
reaction insert with empty reaction and pump pouches. (d) Reaction pouch with orange 
colored water inside after reconstituting the food coloring and pumping through the one-
way valve into the reaction pouch chamber. 
Figure 26: Reconstitution of dried LAMP master-mix reagents. Black solid line is 
reconstituted LAMP master-mix spiked with M.tb genomic DNA (positive). Black 
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dashed line is reconstituted LAMP master-mix without M.tb genomic DNA (negative). 
Amplification of negative sample is most likely due to lab amplicon contamination 
affecting the reagent drying process. 
Figure 27: Amplification of reconstituted master-mix materials. (a) Amplification results 
from two samples reconstituted in the fluidics testbed, with M.tb genomic DNA spiked 
into the reconstitution buffer. Testbed #1 shows amplification while Testbed #2 does not. 
(b) Amplification results from samples reconstituted in standard tubes and amplified on a 
bench-top thermocycler. The reconstituted NTC sample did not contain M.tb genomic 
DNA but does show amplification, likely due to amplicon contamination of lab areas. 
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CHAPTER 1: INTRODUCTION AND THESIS SCOPE 
Nucleic acid amplification testing (NAAT) can be used to diagnose infectious diseases by 
identifying the pathogen’s genetic material.1,2 NAAT is typically performed in 
centralized laboratories by highly-trained personnel on large, complex, expensive 
equipment, which is not ideal for applications that require a rapid answer to facilitate 
treatment and improve patient outcomes.
3-5
 In developing countries, the diagnosis of 
endemic infectious diseases using NAAT in central laboratories is further hampered by 
lack of suitable facilities and trained personnel, and additional logistical challenges.
6-8
  
Point of Care Technologies 
Technologies that enable point-of-care (POC) diagnosis of active tuberculosis (TB) could 
greatly benefit the treatment and containment of the disease,
9
 which in 2011 caused 8.7 
million incident cases, resulting in 1.4 million deaths,
10
 primarily in high TB-burden 
regions of Asia, Eastern Europe, and Sub-Saharan Africa. Rapidly identifying individuals 
with active infectious TB in the field is of critical importance to curb transmission and 
reduce morbidity and mortality.
11,12
 Smear microscopy is commonly used to diagnose 
active pulmonary TB, but requires multiple sputum samples, tedious processing, and 
often has low sensitivity.
6
 Culture methods, the current gold standard for sensitive TB 
diagnosis and drug susceptibility testing (DST),
12
 typically deliver results in 2-8 weeks, 
involve significant biohazard concerns, and, therefore, require expensive biosafety level 3 
laboratory infrastructure and trained personnel. By contrast, NAAT enables sensitive and 
specific TB diagnosis and genotypic drug resistance testing, producing accurate results in 
less than 1 day,
13,14
 not accounting for the time required for sample transfer to a central 
laboratory, and result dissemination to the care provider. POC NAAT eliminates these 
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often substantial delays, enables testing and treatment initiation in the same visit, and can 
significantly improve access of TB patients to proper diagnostic methods. 
The GeneXpert (Cepheid, Sunnyvale, CA) exemplifies the move of NAAT 
towards the point of care.
14
 This fully-automated and integrated bench-top system can 
perform sample preparation, nucleic acid amplification via polymerase chain reaction 
(PCR), and multi-channel real-time fluorescence detection in less than 2 hours.
15-17
 The 
World Health Organization (WHO) has endorsed the GeneXpert MTB-Rif test to identify 
multi-drug resistant tuberculosis (MDR TB). However, the size, cost, and maintenance 
requirements of the GeneXpert instrument may impede broad-scale implementation in 
resource-limited, high-burden countries.
18
 Other PCR-based fully- or partially-integrated 
NAAT systems for infectious disease diagnosis are in development or on the market,
19-22
 
but are relatively expensive systems due to the complexity associated with thermocycling 
and real-time fluorescence detection. Isothermal NAAT requires a single reaction 
temperature, and, therefore, utilizes simplified instrumentation compared to real-time 
PCR. In recent years, significant progress has been made in automating isothermal 
amplification methods within a miniaturized format.
23-26
 Several isothermal NAAT 
assays and systems have entered the US market for infectious disease diagnosis in 
moderate complexity clinical laboratories,
27-29
 with varying levels of process integration, 
system complexity, and ease of use.  
Several groups have developed sample-in to answer-out lab-on-a-chip systems for 
nucleic acid testing.
24-26,30-33
 Microfluidic systems for PCR amplification with real-time 
fluorescence detection
34,35
 have been commercialized as part of the Biomark™ (Fluidigm, 
San Francisco, CA) and BD MAX™ (Becton Dickinson, Franklin Lakes, NJ) systems, 
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which both comprise large bench-top instruments, with sample preparation performed 
off-chip using standard methods. Microfluidic PCR systems such as the Biomark™ have 
significant potential for high-end applications. However, to enable fully-automated 
sample-to-answer nucleic acid testing at the point of care using microfluidic PCR, 
challenges have to be overcome related to overall complexity and cost of both the chip 
and required instrumentation. NAAT for infectious diseases further requires large sample 
input volumes to reach the required limit of detection (LOD). In the case of tuberculosis, 
typical sputum sample input volumes range from 100 µL
13,36
 to several mL.
14
 
Microfluidic systems require a much smaller sample input volume, while mesofluidic 
systems are ideal for processing samples in this volume range. In addition, real-time PCR 
requires thermocycling plus fluorescence optics for detection, which is difficult to 
implement in a compact, low-cost, and robust instrument for use in low-resource settings. 
Isothermal NAAT requires a single reaction temperature, and, therefore, utilizes 
simplified instrumentation, compared to PCR. One such method, the loop-mediated 
amplification (LAMP) reaction, uses four to six primers that recognize multiple 
sequences in the target DNA.
37
 The reaction generates concatenated DNA products with 
high molecular weight and extensive secondary structure. A LAMP assay targeting the 
gyrB gene in Mycobacterium tuberculosis (M.tb) genomic DNA,
38
 coupled to visual 
endpoint detection based on pyrophosphate precipitation, has been applied to TB 
diagnosis in low-resource settings.
39,40
 However, the method is performed manually in 
multiple steps that require additional instruments; the turbidimetric fluorescence-based 
readout requires a UV light source for excitation, and this detection method may give an 
ambiguous result at low target copy numbers. 
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Nucleic Acid Lateral Flow 
Lateral flow devices, as exemplified by pregnancy tests, are well-established for POC 
diagnostics, can be manufactured inexpensively in large quantities, rely on passive 
fluidics, and provide a clear visual readout with no additional instruments required. 
Nucleic Acid Lateral Flow (NALF) has been coupled to PCR
41
 and to many isothermal 
methods.
42-46
 NALF involves either antibody-dependent or antibody-independent 
configurations for endpoint detection of a reaction, with the sensitivity contingent upon 
upstream amplification. Antibody-dependent NALF has been used to detect LAMP 
products
46-49
 by incorporating antigenic labels or haptens into the amplicon. NALF 
detection is then performed using an antibody specific to the label. Antibody-independent 
NALF uses direct hybridization of unlabeled target amplicons to colored oligonucleotide-
functionalized micro-particles and immobilized oligonucleotides on the test strip 
membrane.
41,50
  
Lateral flow devices are well-established for POC diagnostics, can be 
manufactured inexpensively in large quantities, rely on passive fluidics, and provide a 
clear visual readout with no additional instruments required. NAAT systems for 
infectious disease diagnosis commercialized by BioHelix
29
 and USTAR
42
 use a NALF 
cassette to analyze the amplified master-mix. This NALF cassette completely contains 
the amplified master-mix to avoid amplicon carry-over contamination, which is a major 
challenge in NAAT. However, in these systems, NALF detection is performed as a 
separate manual step, after isothermal amplification has been executed on a standard heat 
block. 
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Cartridge Fluidics 
To integrate isothermal DNA amplification with NALF detection in one device requires a 
system that can heat the master-mix at a fixed temperature for a pre-determined time, and 
then pump the amplified master-mix onto the lateral flow strip. While isothermal heating 
can be readily accommodated in a compact, inexpensive instrument, fluid handling on 
disposable chips or inside cartridges typically requires bulky and complex positive 
displacement pumping systems. For example, the Cepheid GeneXpert
16
 uses a 
mechanically actuated piston with a rotating valve. Other systems, including the CARD 
(Chemistry and Reagent Device, Rheonix, Ithaca, NY), the LIAT (lab in a tube, IQuum, 
Marlborough, MA), the Razor and Film Array systems (Idaho Technologies, Salt Lake 
City, Utah), and the Portrait analyzer (Great Basin Scientific, Salt Lake City, Utah), 
utilize pneumatic or mechanical actuation for pumping.
21,22,28,51,52
 Alternatively, 
electrolysis provides an inexpensive mechanism to pump fluids by using hydrogen and 
oxygen gases generated by water electrolysis to exert pressure on a downstream fluid.
53
 
Electrolytic pumping has been used for automated NAAT inside microfluidic devices as 
developed by Motorola
54
 and Combimatrix.
55,56
 
System Overview 
The overall goal of this project is to develop a fully-integrated NAAT device to diagnose 
infectious diseases, such as TB, at the point of care in low-resource settings. The 
envisioned device will be a handheld, closed system that is inexpensive and easy to use. 
Ultimately, this device will combine sample preparation, isothermal DNA amplification 
and lateral flow detection into a single sample-in to answer-out platform. This scheme 
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comprises a disposable cartridge that mates with a reusable handheld electronic device. 
This disposable cartridge will contain all necessary reagents, and will not require 
refrigeration, including during shipping and storage. The handheld electronics device will 
be low-power to enable eventual battery operation, making the entire system field-
deployable. To be appropriate for low-resource settings, the cost of goods and 
manufacturing of our system needs to be very low, ideally less than $10 per cartridge and 
less than $100 for the handheld device. The total assay time, including sample 
preparation, will be approximately 60-90 minutes. In addition, we are designing the 
system to be modular so that multiple cartridges can be run simultaneously by adjusting 
the handheld electronics device to accommodate more than one cartridge. 
 
 
Figure 1: Schematic drawing illustrating system operating principle during process 
execution. Sample is loaded and pushed through a miniaturized bead blender 
(“Omnivalve”), lysing mycobacteria and eluting DNA into downstream chambers where 
it reconstitutes lyophilized amplification master-mix materials. The master-mix is then 
heated, allowing isothermal amplification to occur, and the fluid is then pumped onto 
lateral flow strips where amplified product can be visually detected by the user. 
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 The overall system concept is illustrated in Figure 1. The patient sputum sample 
will be collected in a separate apparatus that will contain disinfecting and liquefying 
reagents. This sample collection device will then be attached directly to the inlet port of 
the cartridge. The sample will be pushed through a proprietary miniature bead blender 
which has been enclosed inside an active valve (Omnivalve, Claremont BioSolutions, 
Upland, CA). While the sample is being pushed through the valve to waste, the blender 
motor agitates the beads inside the blender chamber at ~30,000 RPM, which facilitates 
effective mechanical lysis of the mycobacteria.
57
 Furthermore, the eluted DNA in the 
sample is captured on the beads inside the blender. The active valve is then turned to 
connect the blender chamber with the wash buffer reservoir. An electrolytic pump then 
pushes wash buffer through the blender and into waste to remove contaminants, but 
retaining the DNA bound to the beads inside the blender. After the wash buffer reservoir 
has emptied, an additional 1 mL of air is passed through the blender chamber, in order to 
fully expel the wash buffer from the blender chamber. Initial studies have shown that this 
protocol reduces the amount of wash buffer propogated downstream into the reaction 
master-mix, which is desirable. Following the wash step, the active valve is then turned 
again, to connect the blender chamber to the elution buffer reservoir. Another electrolytic 
pump is utilized to fill the blender chamber with elution buffer, and then the valve is 
turned again to connect to the downstream fluidic pathways. The blender is then turned 
on again, eluting the DNA off the bead matrix and into the buffer solution inside the 
blender chamber. Since the valve already positioned to connect the blender chamber to 
the downstream cartridge fluidics, a third electrolytic pump is activated to force the 
elution fluid out of the blender chamber and into two downstream chambers where it 
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reconstitutes lyophilized amplification reaction reagents. After reconstitution, the third 
electrolytic pump is activated again to push the reconstituted reaction master-mix through 
one-way passive valves into the amplification reaction chambers, where the reaction 
mixture is heated and isothermal DNA amplification can occur. During this process, the 
upstream active valve is turned to the completely closed position, to separate the 
upstream sample preparation fluidics from the downstream amplification and detection 
areas. After amplification, two new electrolytic pumps (one for each reaction chamber) 
push the amplified master-mix through one-way passive valves onto lateral flow strips, 
where amplified product can be visually detected by the user as colored lines on the 
lateral flow strips. The entire process from sample preparation through amplification and 
detection in the cartridge is anticipated to be completed in approximately 60-90 minutes. 
During the design and development of this integrated cartridge, we decided to 
initially divide the fully integrated system into two subsystems: one sample preparation 
module and one amplification and detection module.  
Thesis Scope 
The focus of this thesis is the development of the amplification and detection module, 
which can execute isothermal amplification coupled to lateral flow detection with 
required reagents stored on-board, as well as automated and integrated pumping, heating, 
and timing mechanisms. In Chapter 2, we describe the development of an early prototype 
for a disposable, pouch-based cartridge to automate amplification and detection, in 
conjunction with a compact, inexpensive heater that contains low power electronics. In 
Chapter 3, we describe a novel disposable, miniature check valve design that is suitable 
for large-scale manufacturing. In Chapter 4, we describe a refined amplification and 
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detection cartridge with integrated electrolytic pumps and check valves (as described in 
Chapter 3), plus an improved handheld unit that automates heating, timing and pumping 
for amplification and detection process execution. In Chapter 5, we discuss the fluid 
interface that will integrate the amplification and detection module with the sample 
preparation module into one fully-integrated cartridge, and the development of the on-
board lyophilized master-mix reagent storage and reconstitution. 
This work involves a collaborative effort, including KGI engineers (Drs. Anna 
Hickerson and Hsiang-Wei Lu), KGI scientists (Drs. Supriya Kadam, Eric Houghton, 
Deepali Shinde, and Yvonne Klaue), and summer undergraduate or high school research 
students (Thomas Carey, Kimberly Chen, Winnie Ding and Stephanie Tan), as well as 
input from Claremont BioSolutions engineers (Dr. Robert Doebler, Ryan Talbot and 
Keith Harrington) and scientist (Tanya Ferguson, also from KGI). My contribution to the 
work presented in each chapter is highlighted below (Table 1). An organization chart is 
included in Appendix B. 
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Table 1: My individual contributions throughout this thesis project. 
Chapter Team Collaborators My Individual Contributions 
2: Initial 
Prototype for 
Amplification 
and Detection 
Subunit 
Anna Hickerson, Hsiang-
Wei Lu, Tanya M. 
Ferguson, Deepali N. 
Shinde, Yvonne Klaue 
Participated in original design of cartridge and heater; 
Developed pouch fabrication method; 
Developed lateral flow strip integration into pouches; 
Refined electrolytic pumps; 
Verified cartridge materials-assay compatibility; 
Selected appropriate plastic for injection molding; 
Performed thermal mapping to characterize thermal control 
in the cartridge; 
Manufactured and assembled cartridges; 
Assembled and calibrated heater units; 
Established clean manufacturing methods; 
Conducted all isothermal nucleic acid amplification 
experiments in the cartridges on the heaters 
3: Novel 
Miniature 
Passive Valve 
Anna Hickerson, Hsiang-
Wei Lu, Thomas Carey 
PEEK valve assembly and testing; 
Developed autoclaving protocol for decontamination; 
Validated valve material-assay compatibility; 
Performed statistical analyses on all valve data sets; 
Performed background literature and IP research 
4: Refined 
Prototype for 
Amplification 
and Detection 
Subunit 
Anna Hickerson, Hsiang-
Wei Lu, Thomas Carey 
Participated in iterative redesign of refined cartridge and 
instrument; 
Characterized polycarbonate thermal bonding; 
Redesigned lateral flow chambers for proper fluidic 
performance; 
Manufactured components and assembled cartridges;  
Participated in clean-manufacturing process development;  
Participated in fluidic characterization of cartridge; 
Verified assay compatibility of new cartridge components 
and materials; 
Conducted all LAMP assay tests within the cartridges, 
including external verification of LAMP product 
formation via gel electrophoresis 
5: Reagent 
Stabilization 
and 
Reconstitution 
Hsiang-Wei Lu, Supriya 
Kadam, Eric Houghton 
Designed and tested reagent storage and reconstitution fluidic 
interface module; 
Characterized and selected microfiber material; 
Participated in the development of the reagent drying 
process; 
Designed and manufactured fluidic testbeds for 
characterization of master-mix reagent reconstitution and 
amplification; 
Conducted all reconstitution and amplification tests on fluidic 
testbeds 
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CHAPTER 2: INITIAL PROTOTYPE FOR AMPLIFICATION AND 
DETECTION SUBUNIT 
Introduction 
The key functional components of the amplificiation and detection subunit include a 
double pouch system with an inner reaction pouch enclosed by a pump pouch, which is 
part of the pumping mechanism to move fluid out of the reaction pouch. The reaction 
pouch requires an inlet to introduce master-mix into the pouch, and an outlet that 
interfaces the lateral flow strip for detection. The pump pouch is connected to an 
electrolytic pump. The system is heated to a controlled and constant temperature for the 
duration of the isothermal amplification reaction. While designing and demonstrating 
functionality of these key components, we developed an intial disposable cartridge 
prototype, in conjunction with a handheld heater prototype. We have demonstrated as 
proof of principle the amplification and detection of Mycobacterium tuberculosis (M.tb) 
genomic DNA in the cartridge, using either Loop Mediated Amplification (LAMP) or the 
Exponential Amplification Reaction (EXPAR), both coupled to Nucleic Acid Lateral 
Flow (NALF) detection.  
Experimental 
System Design and Operating Concept: Our system design, illustrated in Figure 2, allows 
two samples to be tested simultaneously. The disposable cartridge contains on its top side 
two lateral flow strips in anti-parallel orientation, two septum inlets through which 
master-mix is injected, and two attachment ports for electrolytic pumps (Figure 2a). Two 
reaction pouches are attached to the bottom side of the cartridge (Figure 2b), accessible 
through septum inlets and outlets containing passive, one-way check valves that lead to 
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the lateral flow strips. The bottom side of the cartridge also contains two pump pouches 
sealed on top of the reaction pouches, which are connected to the electrolysis chamber 
ports. The electrolysis chambers and the pump pouches are filled with electrolyte solution. 
During process execution, an empty cartridge is attached to the handheld, non-
disposable heating and electronics unit, where the cartridge is pre-heated to the reaction 
temperature. After the cartridge has reached the appropriate operating temperature, 
reaction master-mix is injected from the top (Figure 2c), through the septum inlet port, 
into the reaction pouch, which initiates isothermal DNA amplification. Once the reaction 
is completed, current is applied to the electrodes (Figure 2d) and the pump pouch is 
pressurized with gas produced via electrolysis. The pressurized pump pouch pushes the 
fluid within the reaction pouch up through the outlet port and onto the lateral flow strip. 
The reaction mixture migrates along the strip through passive capillary action, wicking 
across test and control areas of the strip where colored microspheres can bind, producing 
a visual readout. The lateral flow strips are also sealed in pouches, ensuring that all fluids 
remain sealed within the disposable cartridge, eliminating carry-over contamination of 
amplicons.  
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Figure 2: Conceptual drawing of system components. (a) Cartridge viewed from the top, 
showing the access ports to the reaction and pump pouches on the underside of the 
cartridge (indicated in gray outline), and the position of lateral flow strips in anti-parallel 
orientation. (b) Cartridge viewed from the bottom, showing the reaction pouches with 
overlaid pump pouches. (c) and (d) Side view of the cartridge on the heater (not to scale), 
illustrating the operating principle. (c) Master-mix is injected through the septum inlet 
into the reaction pouch, and targeted DNA sequences are isothermally amplified on top of 
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the temperature-controlled heater surface. (d) Applying current to the electrolytic pump 
pushes fluid into the pump pouch. The pump pouch expands, thereby compressing the 
reaction pouch up against the dome-shaped recess in the cartridge, which forces fluid out 
of the reaction pouch through the one-way check valve and into the lateral flow strip 
pouch. 
 
Cartridge Fabrication: The cartridge uses low-cost components and manufacturing 
techniques to meet the cost constraints of POC testing performed in low-resource settings. 
The main cartridge components are manufactured using injection molding and thermal 
bonding, both of which are inexpensive and scalable techniques.  
The body of the cartridge consists of two polypropylene cards, which were 
injection molded in-house from USP Class VI polypropylene pellets (Pro-fax SR256M, 
PolyOne, Inc., Rancho Cucamonga, CA) using a G-100T injection molding press from 
Morgan Industries (Long Beach, CA). The cards include hollow protrusions in matching 
locations, which can be joined to form fluid conduits that allow fluid to pass from the 
bottom surface of the bottom card to the top surface of the top card. One-way passive 
ball-and-spring valves (CCPI2510014S, the Lee Company, Westbrook, CT) were pressed 
into the hollow protrusions of the bottom card, leading from the reaction pouches to the 
lateral flow strip pouches (Figure 2a, check valve outlet). To create a silicone inlet 
septum, short pieces of silicone cord (McMaster-Carr, Santa Fe Springs, CA) were 
inserted into the hollow protrusions on the top card, serving as inlets into the reaction 
pouches (Figure 2a, septum inlet). Next, 0.005 inch thick flexible polypropylene film 
(Qosina, Edgewood, NY) was heat-sealed onto the bottom card to create two reaction 
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pouches overlaid by two pump pouches (Figure 3a). Lateral flow strips were inserted into 
grooves on the top card, and polypropylene film was heat-sealed onto the card to create 
two lateral flow strip pouches (Figure 3b). Heat-sealing was performed using custom-cut 
aluminum dies to produce pouches of various geometries, attached to a custom-built heat 
press with a temperature-controlled aluminum block mounted to an arbor press for safety 
and leverage. After attaching the pouches, the two cards were pressed together, creating a 
snap-fit seal and leak-proof fluid conduits between the two cards. We then inserted 
silicone foam insulation (85925K115, McMaster) cut to the appropriate shape between 
the top and bottom cards. To complete the cartridges, two large reservoirs (Qosina) were 
press fit into the fluid conduits that provide access to the pump pouch (Figure 2a, pump 
inlet), thus forming the electrolyte chambers on the top of the cartridge (Figure 3b). We 
used standard 18 gauge stainless steel syringe needle tips to fill the chamber and pump 
pouch with 1 M aqueous Na2SO4 electrolyte solution through the septum on top of the 
reservoir chamber. The two needles were then capped closed, but were left in the septum, 
to be used as electrodes for electrolytic pumping. 
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Figure 3: Cartridge and instrument. (a) Underside of cartridge, showing two reaction 
pouches sealed inside two pump pouches on the bottom surface of the bottom card. (b) 
Top side of cartridge: lateral flow strips are sealed inside the grooves forming the lateral 
flow strip pouches, and electrolytic chambers are press-fit in place. Not shown: silicone 
foam is placed between the cards, and pump chambers are filled with electrolyte solution 
to complete the assembly. (c) Small portable prototype heater, which contains the control 
electronics, thin-film polyimide heater, an aluminum heater surface, and thermal 
insulation below the heater and around the perimeter of the area where the cartridge is 
inserted. (d) Heater with a cartridge secured in place (grey lid), prior to test execution. (b) 
and (d) The red line on the NALF strips represents the dry reagent formulation with 
colored microspheres dispensed on the conjugate pad. 
 
Portable Heater Fabrication: We designed and fabricated a reusable handheld instrument 
(Figure 3c) to apply a precise and controlled temperature to the reaction fluid within the 
disposable cartridge (Figure 3d). The set-point of the heater can be adjusted to reach the 
temperature required for a particular isothermal reaction, e.g. 63 °C for LAMP and 55 °C 
for EXPAR. The chassis of the heater instrument was printed with acrylonitrile butadiene 
styrene (ABS) using a Dimension SST 768 fused deposition modeling machine. Thin-
film polyimide heaters (Omega) were attached to a 1/8th inch thick aluminum plate to 
provide evenly-distributed heating. Polyurethane foam sealant (Dow Chemical), applied 
to the surrounding area, minimizes the power required to reach and maintain the required 
temperature for isothermal amplification. We controlled the temperature using a custom 
printed circuit board (PCB) to adjust the power to the heaters based on feedback from a 
17 
 
thermistor embedded near the center of the top surface of the aluminum plate. The 
instrument was powered by a 15 V wall transformer, using ~ 8 W during the initial ~ 3 
minutes heating ramp, and ~ 0.5 W to maintain the temperature. 
 
Thermal Control Testing and Modeling: Precise temperature control is essential for this 
system, as the amplification reaction kinetics are related to assay fluid temperature. We 
measured the temperature of the heater surface as a function of time using a DirecTemp 
(Redfish Sensors, Meridian, ID) universal serial bus (USB) thermistor-based sensor probe. 
To directly measure the temperature of the fluid in the reaction pouches as a function of 
time, we inserted a thermocouple (5TC-TT-K-36-36, Omega, Stamford, CT) into the inlet 
of a reaction chamber filled with water while the cartridge was attached to the heater. We 
measured the cartridges under three different conditions: with empty pump pouches (no 
electrolyte solution), with pump pouches filled with electrolyte solution, and with pump 
pouches filled with electrolyte and a thin layer of thermal paste (OmegaTherm “201”, 
Omega, Stamford, CT) applied to the underside of the cartridge on the outside of the 
pump pouches. 
We modeled the three-dimensional temperature profile within the system as a 
function of three factors: the overall system design, the choice of materials, and the 
thermal contact between cartridge and heater. Thermal simulations were performed using 
COMSOL Multiphysics (Burlington, MA), based on the three-dimensional cartridge and 
instrument geometry imported from Solidworks (Glendora, CA). The model treats the 
thin-film heater as a two-dimensional heat source on the bottom of the aluminum heater 
plate, with a specified output power. The heat conducts through the interior of the 
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cartridge and dissipates to the room-temperature environment by convection to still air 
through the top surface of the cartridge, or through insulating material on the sides of the 
cartridge. Convection through still air is imposed using a natural convection boundary 
with a Dirichlet heat flux based on: NV = (5 W) / (m
2
 K). We modeled the non-ideal 
thermal contact between the cartridge and the heating surface by incorporating a 
thermally resistive layer. 
 
Isothermal Amplification Reactions: For this proof of principle study, we implemented 
two isothermal DNA amplification reactions in the device to detect M.tb genomic DNA, 
coupled with NALF visual endpoint detection: an established and clinically validated 
LAMP reaction, and an in-house developed EXPAR reaction. 
For isothermal LAMP targeting the M.tb gyrB genomic region, we modified 
primer sequences (Table 2Table ) and reaction conditions from Iwamoto et al.
38
 to work 
in our system with lateral flow detection of amplified products. The 100 µL LAMP 
master-mix contained 20 mM Tris-HCl, pH 7.9, 15 mM ammonium sulfate, 30 mM 
potassium chloride, 0.005% Triton X-100, 2 mM magnesium chloride, 2 mM magnesium 
sulfate, 400 µM each dNTP (Fermentas, Glen Burnie, Maryland), 1 M betaine, 200 
µg/mL bovine serum albumin, 2.4 µM Forward Inner Primer (FIP), 1.6 µM Backward 
Inner Primer (BIP, DIG-labeled), 0.2 µM of each outer primer (F3 and B3), 0.4 µM 
biotinylated Forward Loop Primer (bio-LF), 0.8 µM Backward Loop Primer (LB), and 20 
U of Bst DNA Polymerase large fragment (New England BioLabs, Ipswich, MA). Each 
reaction further contained 10 ng human genomic DNA (Promega, Madison, WI) as 
general background. Positive reactions contained 3000 copies of M.tb H37Ra genomic 
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DNA (ATCC, Manassas, VA) as the template, which was omitted in the No Template 
Control (NTC) negative reactions. To characterize the assay performance, LAMP 
reactions were amplified on a thermocycler set to 63 °C for the same time period as was 
used for amplification in the cartridges. Amplified LAMP master-mix was then analyzed 
using gel electrophoresis on a 2 % eGel (Invitrogen, Life Technologies, Carlsbad, CA).  
Table 2: Oligonucleotide Sequences for LAMP Amplification and NALF Detection 
Name Sequences 
Forward Outer Primer 
Backward Outer Primer 
Forward Inner Primer 
Backward Inner Primer 
Forward Loop Primer 
Backward Loop Primer 
NALF Conjugate Probe 
NALF Test Line 
NALF Control Line 
GCGATATCTGGTGGTCTGC 
CCGTGGTTTCGAAAACAGC 
AGACCACTCGTACCCGTCGCCGGTGGTTAACGCGCTAT 
DIG-sp9-ATGAGAAGTCGGAACCCCTGGGACCGTTGACCCCGTCTTC 
biot-TEG-sp18-TTGATCTCGACTTCGAGCC 
CCTCAAGCAAGGGGCG 
NH2-sp12-d(T)90 
anti-Digoxin 
biot-TEG-d(A)60 
DIG = digoxygenin; sp9 = C9 spacer; biot-TEG = biotin-tetra-ethylene glycol; sp18 = C18 spacer; sp12 = 
C12 spacer 
 
EXPAR was also executed in the cartridge, which is initiated by a short trigger 
oligonucleotide (Trigger X) that can be generated from a targeted site within genomic 
DNA through the Fingerprinting reaction.
58
 Trigger X primes and is extended along an 
oligonucleotide provided in the EXPAR master-mix, called the first stage amplification 
template. The template consists of two times the complimentary sequence X’, separated 
by nine bases that enable generation of a nicking enzyme recognition site upon 
polymerase extension. The nicking enzyme, Nt.Bst, recognizes this sequence and reaches 
four bases to the 3’ end of the recognition site to nick the top strand. This nick creates 
another short oligonucleotide trigger that melts off the amplification template. The 
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polymerase elongates the recessed 3’-hydroxyl, created by the departing trigger, and the 
process repeats. Newly formed triggers then prime other amplification templates, creating 
true chain (exponential) reactions. Trigger X is generally 10 to 16 bases long, although 
the genomic sequence required for trigger generation is much longer (typically ~ 28 bp). 
In two-stage EXPAR, Trigger X is converted to a reporter oligonucleotide (Reporter Y), 
which can be detected through a colorimetric assay using DNA nanosphere aggregation,
59
 
or via NALF, as described herein (Figure 4). 
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Figure 4: Conceptual depictions of EXPAR reactions and coupling the amplification 
products with NALF. (a) First-stage EXPAR, where Trigger X primes and is extended 
along a template provided in the EXPAR master-mix. (b) Second-stage EXPAR 
illustrating Trigger X converting to a reporter oligonucleotide (Reporter Y). (c) NALF 
coupled to second-stage EXPAR, where the Reporter Y oligonucleotide binds DNA-
functionalized microspheres and DNA hybridized on the nitrocellulose at the test line, 
resulting in a visible test line. This binding is dependent on the presence of Reporter Y, 
so the test line will only be present in positive samples. Additional DNA functionalized 
on the microspheres will bind DNA hybridized on the nitrocellulose at the control line, 
resulting in a visible line. The binding at the control line is independent of the presence of 
Reporter Y, and, therefore, acts as an indicator of proper lateral flow function. 
 
EXPAR was carried out in a reaction mixture containing 0.3 units/µL Nt Bst 
nicking enzyme (New England Biolabs, Ipswich, MA), 0.03 units/µL Bst polymerase 
(NEB), 0.24 mM dNTPs (Fermentas, Glen Burnie, Maryland), 1.6 mg/mL bovine serum 
albumen (New England Biolabs), 3 mM magnesium chloride (Sigma-Aldrich, St. Louis, 
MO), 1x SYBR Green I (Invitrogen), 20mM Tris pH 7.9, 15mM ammonium sulfate, 
30mM potassium chloride, 0.005% Triton X-100, 1.6 mg/mL BSA, 25 nM first stage 
EXPAR template, and 50 nM second stage EXPAR template. Positive reactions 
contained 6x10
5
 copies of M.tb H37Ra genomic DNA, but not in the no trigger control 
(NTC) negative reactions. Template and trigger sequences are shown in Table 3. Each 
reaction further contained 10 ng human genomic DNA (Promega, Madison, WI) per 
reaction as general background. In parallel with experiments performed on the cartridges, 
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positive and negative control reactions (75 μL volume) were amplified in a Bio-Rad 
(Hercules, CA) MJ Opticon II real-time thermocycler set to a constant temperature of 
55 °C, and the fluorescence intensity was monitored in 10 second intervals using 
excitation at 488 nm over a period of up to 2 hours to verify reaction kinetics. 
 
NALF Test Strip Fabrication: LAMP-NALF test strips were fabricated in-house, using 
the probe and control oligonucleotides shown in Table 2, synthesized by Eurofins MWG 
Operon (Huntsville, AL). Oligo d(T)90 and neutravidin were conjugated respectively to 
red-dyed carboxylate modified polystyrene microspheres (0.4 µm; Thermo Fisher 
Scientific) using 1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) 
as the cross-linker. Following the conjugation process, the microspheres were re-
suspended and stored in 50 mM Sodium Borate, pH 8.4, at a final microsphere 
concentration of 1%. The anti-Digoxin antibody (MyBioSource, San Diego, CA) was 
diluted to 1 mg/ml in 10 mM Tris, pH 7.4, plus 5% ethanol and the biotinylated control 
line d(A)60 oligonucleotide was coupled to neutravidin at room temperature. Both were 
then dispensed as even and reproducible lines onto a nitrocellulose membrane (Sartorius, 
Goettingen, Germany) using a lateral flow reagent dispenser (ALFRD 07.711.01, 
Claremont BioSolutions, Upland, CA). After dispensing the capture antibody and the 
control line oligonucleotide probe, the nitrocellulose was dried at room temperature for at 
least 30 minutes, and was subsequently stored in a sealed, desiccated, moisture-barrier 
pouch.  
 EXPAR-NALF test strips were also fabricated in-house, using the probe, test, and 
control oligonucleotides shown in Table 3, obtained from Operon Biotechnologies 
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(Huntsville, AL). Red-dyed carboxylate-modified polystyrene microspheres 
(ThermoFisher Scientific) were covalently coupled to the amine modified probe 
oligonucleotide, using Ethyl-N′-(3-dimethylaminopropyl) carbodiimide hydrochloride 
(EDAC, Sigma, St. Louis, MO) under conditions adapted from Spiro et al.
60
 Following 
the conjugation process, the microspheres were re-suspended and stored in 50mM 
Sodium Borate, pH 8.4 at a final microsphere concentration of 1%. The biotinylated test 
and control oligonucleotides were coupled to Neutravidin at room temperature and then 
dispensed as even and reproducible lines onto a nitrocellulose membrane (Sartorius, 
Goettingen, Germany) using an in-house manufactured reagent dispenser. Following 
dispensing, the nitrocellulose was allowed to dry at room temperature for at least 30 
minutes, and was subsequently stored in a sealed desiccated moisture barrier pouch. 
 
Table 3: Oligonucleotide Sequences for EXPAR Amplification and NALF Detection 
Name Sequences 
Fingerprinting site 
First stage template 
Second stage template 
NALF conjugate probe 
NALF test line probe 
NALF control line probe 
5’- GAGTCCAGTATTTGGTCGTCTGTCCTGCGTAGCGACTC -3’ 
5’- ATTTGGTCGTCGCAGACTCATTTGGTCGT -3’ 
5’- ACCGGGCAGATTCGGCCCACTTCCCGCAGACTCATTTGGTCGT -3’ 
5’- [AmC6]TTTTTTTTTACCGGGCAGATT -3’ 
5’- CGGCCCACTTCCTTTTTTTTT-sp18-biotin -3’ 
5’- biotin-sp18-AATCTGCCCGGTAAAA -3’ 
Finger printing site located at position 2574824 within the M.tb H37Rv reference genome (accession # 
CP003248.1). Template design: Sequences underlined with a solid line depict the trigger complement 
sequence X’, and bold letters mark the location of locked nucleic acid. Dotted lines indicate the 
complementary reporter sequence (Y’) used for lateral flow detection. AmC6 = 5’ amine-modified with C6 
spacer; sp18 = C18 spacer 
 
The glass fiber conjugate pad (Millipore Corp, Bedford, MA) was dipped into a 
custom conjugate-releasing solution and dried for 10 - 15 minutes at 55 °C – 60 °C. The 
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conjugated polystyrene microspheres were then dispensed as a line onto the conjugate 
pad using the reagent dispenser set to a flow rate of 7 µl/cm. The conjugate pad was dried 
for 5 minutes at 55 °C – 60 °C, and then stored in a sealed, desiccated, moisture-barrier 
pouch. 
To prepare test strips, we mounted the dispensed nitrocellulose membrane to an 
adhesive plastic backing (G & L Precision Die Cutting, San Jose, CA). The treated glass 
fiber conjugate pad and a cellulose fiber absorbent pad (Millipore Corp.) were 
respectively attached to the bottom (sample) and the top portions of the adhesive backing, 
each with a 1 - 2 mm overlap with the nitrocellulose membrane. The resulting sheet was 
cut into 4 mm x 50 mm individual test strips for assembly into the cartridge. 
 
Amplification and Detection in the Cartridge: For amplification and detection in the 
cartridge, we pre-heated the empty cartridge on the heater for 10 minutes. In LAMP 
cartridges, LAMP master-mix solutions for the positive and NTC reactions (100 µl each) 
were then injected into the reaction pouches, and amplified on the heater for 10 minutes. 
In EXPAR cartridges, EXPAR master-mix solutions for the positive and NTC reactions 
(75 µl each) were then injected into the reaction pouches, and amplified on the heater for 
60 minutes. For all cartridges, electrolytic pumping was initiated after heating to push the 
amplified master-mixes out of the reaction pouches and into the lateral flow pouches, 
where the samples migrated along the NALF strips. The results were visually interpreted 
by reading the test and control lines 10 minutes after pumping was initiated. 
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Results and Discussion 
Fluidic Control: This cartridge utilizes electrolytic pumping and therefore does not 
require external pistons or actuators, as opposed to other clinical diagnostic systems using 
flexible pouches.
21,22,28
 Similar to previous reports,
53
 we have observed a roughly linear 
relationship between applied current and flow rate for electrolytic pumping. To ensure 
that the lateral flow strips perform properly, we determined that amplified master-mix 
needs to be pumped from the reaction chamber into the lateral flow strip chamber at a 
flow rate of approximately 100 µL/min, which was obtained by applying 50 mA of 
current. 
One-way valves are necessary to prevent the fluid within the reaction chamber 
from leaking prematurely into the lateral flow detection chamber. Injecting 75-100 µL 
liquid into the reaction chamber results in < 2 PSI fluid pressure, which is less than the 
cracking pressure of the valves (~ 2 PSI) used in the current design. Therefore, fluid is 
retained in the reaction pouch until electrolytic pumping forces the fluid through the 
valve and onto the lateral flow strip. 
 
Instrument Design and Thermal Control: Maintaining an appropriate and uniform 
temperature throughout the reaction pouch during the amplification period is essential for 
assay performance. With a cartridge inserted into the device, the heater surface requires 
approximately three minutes to heat from room temperature to 63 °C, and maintains this 
constant temperature to within ±0.1 °C for as long as the heater is turned on. Comparable 
temperature stability is obtained at other temperatures, e.g. 55 °C required for EXPAR. 
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Air trapped between the fluid inside the reaction pouch and heater surface significantly 
lowers the thermal conductivity across this interface, and can contribute to non-uniform 
fluid heating within the reaction pouch. This concern can be mitigated by filling the 
pump pouch with fluid. The slightly inflated pump pouch presses up against the heater 
surface, which compensates for imperfections on the cartridge bottom surface that 
prevent the cartridge from sitting completely flat on the heater. Additionally, the fluid in 
the pump pouch effectively conducts heat to the reaction pouch. We measured the 
temperature of liquid in the reaction pouch using a thermocouple inserted through the 
inlet septum. If the pump pouch is empty, then the fluid temperature in the reaction pouch 
deviates significantly from the temperature measured directly on the heater surface 
underneath the cartridge (Figure 5a). Filling the pump pouch improves the thermal 
transfer efficiency between heater surface and cartridge, resulting in temperature 
equilibration after ~ 10 minutes, and a final temperature closer to the desired set-point. 
Thermal paste applied between the heater surface and pump pouch provides no further 
improvements. 
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Figure 5: (a) Measured temperature of the fluid inside the reaction pouch of a cartridge 
attached to the heater as a function of time. Filling the pump pouch with liquid improves 
the thermal transfer from the heater to the reaction fluid, which reaches a stable 
temperature of 62±0.1 °C within approximately ten minutes. Thermal paste applied 
between the heater surface and pump pouch provides no further improvements. (b) and (c) 
Thermal simulations (COMSOL Multiphysics) of the cartridge on top of the heater, 
showing horizontal cross-sections within the center of the reaction fluid layer of the 
cartridge. (b) Uniform heating to the desired temperature (63 °C) is observed using a 
model with ideal thermal contact between cartridge and heater, with no air gap. (c) 
Introducing a 150 µm thick thermally-resistive layer between cartridge and heater leads 
to a lower temperature and less uniform heating within the reaction pouch. The cross-
hatches in the middle of the pump pouches indicate the dimensions of the circular 
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reaction pouches. An air bubble was intentionally introduced into the outlet port of the 
reaction chamber to simulate air trapped in the reaction pouches after fluid is inserted. 
 
Using our mathematical model, we found that the temperature within the reaction 
pouches deviated from 63 °C by less than 0.5 °C throughout the reaction chamber if the 
cartridge makes ideal contact with the heater surface (Figure 5b). To understand the 
effects of non-ideal thermal contact, we modeled the system with a 150 µm thick 
thermally-resistive air layer between the pump pouches and the heater surface (Figure 5c). 
This resistive layer significantly reduced the heat transfer between the heater and 
cartridge, decreasing the maximum temperature in the reaction pouches by 1 °C, and 
leading to more significant temperature variation throughout the reaction pouch.  
 
Isothermal Amplification Methods: We designed out system to work with any isothermal 
amplification method coupled to lateral flow, to detect genetic material of any disease. 
For preliminary studies, we have decided to run two amplification methods targeting M.tb 
genomic DNA: LAMP and EXPAR. These reactions have distinct advantages and 
disadvantages in terms of integration into the cartridges. For example, in previous work 
we optimized coupling EXPAR amplification to NALF detection.
61
 Therefore, for 
EXPAR implementation in the cartridges, we needed to design EXPAR templates for 
detection of M.tb genomic DNA, and demonstrate target amplification with NALF 
detection. On the other hand, a LAMP assay was previously clinically-validated in 
another lab for the detection of M.tb.
38
 Consequently, for LAMP implementation in the 
cartridges, we needed to develop a method for coupling LAMP to NALF, as described 
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below. By using two different amplification methods coupled to lateral flow detection, 
we are able to demonstrate proof of concept for the cartridge and handheld heater system 
as a platform technology which could be modified for other applications. 
 
Lateral Flow Detection on Cartridge: The cartridge was designed to run two samples per 
cartridge. This dual-processing design could increase throughput by allowing for multiple 
simultaneous tests, or could allow for duplicate testing on one cartridge from the same 
original sample. 
 Additionally, the lateral flow strips were positioned in anti-parallel orientation on 
the top surface of the cartridge. This design was developed as a way to best use the 
footprint of the cartridge top surface while also utilizing the existing inlet and outlet fluid 
conduits between the top and bottom cartridge pieces. The lateral flow strips were 
modified to be shorter (~ 4 cm) than standard lateral flow strips (~ 5 cm), to facilitate 
installation on the cartridges. By orienting the strips anti-parallel, we were able to fix the 
lateral flow strip pouches over outlet fluid conduit, to connect directly with the reaction 
pouch chamber, but without covering the matching inlet fluid conduit to the other 
reaction pouch chamber on the opposite end of the cartridge. 
 
Isothermal Amplification Coupled to NALF Detection: To establish proof of principle 
that isothermal amplification coupled to lateral flow detection can be executed in the 
cartridge on the heater device, we chose two isothermal amplification reactions that 
detect M.tb genomic DNA as the target. The first reaction is an established, clinically-
validated LAMP assay that has been used for TB diagnosis in low resource settings.
38,39
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We have modified this assay to enable coupling with NALF detection (Figure 6). 
Coupling LAMP to NALF has been demonstrated for other assays,
46
 but the complicated, 
large amplicon structure can cause steric hindrance that may result in compromised line 
intensities and test results. 
 
 
Figure 6: Conceptual depiction of NALF detection coupled to LAMP. (a) Amplified 
master-mix applied to the conjugate pad enables amplicons to interact with colored 
polystyrene microspheres functionalized with appropriate capture moieties. (b) After 
migrating along the nitrocellulose membrane, microspheres carrying amplicons are 
captured at the test line. (c) At the control line, microspheres are captured irrespective of 
the presence of amplicon. 
 
Our approach for LAMP amplicon detection via NALF uses a somewhat different 
reaction scheme than that described for coupling EXPAR to NALF. In positive reactions, 
the LAMP master-mix contained biotin/DIG-labeled amplicons. Through the biotin 
moiety, amplicons were captured by the neutravidin-conjugated microspheres. After 
migrating along the nitrocellulose strip, microspheres carrying LAMP amplicons were 
captured at the test line (T), based on the interaction between the DIG-labeled portion of 
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the LAMP product and the immobilized anti-DIG antibody (Figure 6b). At the control 
line (C), the oligo-d(A) immobilized on the nitrocellulose membrane hybridized to the 
oligo-d(T) conjugated to the microspheres (Figure 6c). This control line confirms proper 
performance of the lateral flow strip, and should appear in positive and negative reactions 
as hybridization is independent of the presence of LAMP amplicons. In contrast, the test 
line should only appear in positive reactions. In addition, many NALF reactions require 
an extra liquid running buffer, which introduces another reagent and complicates the 
device design. In our LAMP-NALF scheme, amplified master-mix can be applied 
directly to the conjugate pad of the NALF strip, where it reconstituted a dry reagent 
mixture containing colored microspheres. No other liquid reagents are required other than 
the amplified master-mix. 
The second assay used herein is EXPAR, which amplifies short trigger 
oligonucleotides at 55 °C using polymerase and nicking enzyme activities.
58
 In prior 
work, we have demonstrated that the trigger oligonucleotide amplified in EXPAR can be 
generated from a targeted genomic DNA sequence that contains adjacent nicking enzyme 
recognition sites through the Fingerprinting reaction,
61
 and have implemented EXPAR in 
a two-stage reaction format to generate a reporter oligonucleotide that can be detected via 
a nanosphere based colorimetric readout.
59
 We detected M.tb genomic DNA through a 
Fingerprinting two-stage EXPAR assay with NALF-based readout. Two-stage EXPAR 
generates large amounts of single-stranded reporter oligonucleotide Y that can form a 
sandwich complex with complementary probe oligonucleotides conjugated to 
microspheres and to the test line of a NALF strip (Figure 4c). Therefore, the test line 
becomes visible in positive reactions. The probe oligonucleotide immobilized at the 
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NALF control line hybridizes directly to the probe sequence conjugated to the 
microspheres. Therefore, the control line appears in positive and negative reactions. 
Again, we developed an EXPAR-NALF strip with a dry reagents mixture in the 
conjugate pad, to which amplified master-mix can be applied directly without the need 
for additional liquid reagents. 
 
Amplification and Detection in the Cartridges: We tested the performance of both 
isothermal assays coupled to NALF detection in the cartridge prototype. For these 
experiments, the heater set-point was adjusted for the desired reaction temperature (63 ºC 
for LAMP and 55 ºC for EXPAR), and a cartridge with empty reaction chambers was 
allowed to pre-heat on the heater for ten minutes. We then injected master-mix through 
the inlet septum into the reaction chambers, with one positive and one negative reaction 
per cartridge. We allowed the reaction to incubate on the heater for 10 minutes (LAMP) 
or 60 minutes (EXPAR), then applied current to the electrolytic pumps, and allowed 10 
minutes for NALF detection. The final readouts for LAMP-NALF (Figure 7a) and 
EXPAR-NALF (Figure 7c) consisted of the expected two lines (T = test and C = control) 
for the positive and a single line (control) for the negative reactions. For LAMP we also 
determined that master-mix amplified in the cartridge produces the same characteristic 
pattern of high molecular weight amplicons as control reactions performed under 
standard conditions (Figure 7b). 
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Figure 7: Amplification results. (a) LAMP based detection of M.tb genomic DNA 
performed in the cartridge on the instrument: NALF strips of two representative 
cartridges, after 10 minutes of isothermal amplification, followed by 10 min for lateral 
flow detection. (b) LAMP master-mix amplified in the cartridge on the heater, analyzed 
via gel electrophoresis (Lanes 1 and 2), compared to amplification performed in reaction 
tubes on a standard heat block (Lanes 3 and 4). Lane 5: DNA molecular weight markers. 
For (a) and (b), positive (+) reactions show LAMP product starting from 3000 copies of 
M.tb DNA, and negative (-) reactions show no product since no M.tb DNA was added to 
the reaction. (c) EXPAR based detection of M.tb genomic DNA performed in the 
cartridge on the instrument: NALF strips of two representative cartridges, after 60 
minutes of isothermal amplification, followed by 10 min for lateral flow detection. 
Positive (+) reactions contained 6x10
5
 copies M.tb DNA, and negative (-) reactions 
contained no M.tb DNA. 
 
For LAMP, positive reactions contained 3000 copies of M.tb genomic DNA, 
while for EXPAR, positive reactions contained 6x10
5
 copies of M.tb genomic DNA. 
Relatively high concentrations of target genomic DNA were chosen as a means of 
establishing proof of principle for the cartridge prototype. The goal of the study reported 
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herein was not to test the limit of detection for the assays. In both cases, negative 
reactions contained no M.tb genomic DNA, but all reactions included 10 ng human 
genomic DNA, which is present as background in clinical samples. The assays are not 
cross-reactive with human genomic DNA. LAMP produced results after 10 minutes of 
isothermal amplification, likely due to the relatively high starting copy number.
38
 The 
EXPAR assay, which still needs to be optimized, required longer amplification under the 
current reaction conditions. 
Conclusions 
Using the system and assay reported herein, we have demonstrated detection of 
purified M.tb genomic DNA through isothermal LAMP and EXPAR reactions coupled 
with NALF in a fully-enclosed combined format. Through this early prototype, we 
obtained suitable thermal control, and have established proof of principle for the novel 
fluid handling approach using two-layer pouches combined with one-way valves and 
electrolytic pumping. This system is capable of executing different isothermal 
amplification reactions coupled with NALF detection, such as the LAMP and EXPAR 
assays described herein. 
This system was developed as a step towards the goal of enabling point-of-care 
infectious disease diagnosis in low-resource settings. We are refining the design of this 
amplification and detection subunit
62
 (Chapter 4) to incorporate miniaturized and 
integrated electrolytic pumps and novel passive valves
63
 (Chapter 3), and to enable 
automated pumping, heating, and timing.  
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CHAPTER 3: NOVEL MINIATURE PASSIVE VALVE 
Introduction 
Valves are an essential component for the control and manipulation of ﬂuids. Many 
passive and active valve designs exist, each with their own advantages and limitations.
64-
68
 The small passive valves presented in this paper offer a combination of attributes not 
readily met by commercially available stand-alone passive valves, such as ball-and-
spring, duckbill, and umbrella valves. These attributes include small dead volume, 
selectable non-zero cracking pressure, and the ability to be mass manufactured at low 
cost. Valves used in medical diagnostics and devices also have to be compatible with 
certain biomaterials, such as enzymes and other reagents used in clinical diagnostic 
applications.
68-70
 Our disposable cartridges for point-of-care nucleic acid testing require 
passive check valves with the attributes mentioned above.
62
 None of the currently 
available commercial options were able to meet all our desired criteria. For example, the 
Lee Company (Westbrook, CT) produces a ball-and-spring valve that meets all the 
physical requirements but is cost prohibitive. The remaining valve options all had 
recommended installation conﬁgurations that created a dead volume too large for a 
typical diagnostic assay, among other challenges.  
Specialized valves made using microfabrication techniques,
67,71-76
 such as 
photolithography, can be very small and often have negligible dead volumes. However, 
these techniques require the valve to be, at least in part, fabricated in the same way and at 
the same time as the system with which it is integrated. This limits the design options 
greatly. Furthermore, linking macro and micro volumes in microfabricated designs is a 
signiﬁcant challenge, one that is essential for diagnostic systems that require large initial 
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sample input volumes and much smaller volumes during final analysis. The valve design 
presented herein can be made using commercially available sub-components, is low cost 
and easy to assemble. The valve is manufactured independently from the system into 
which it is inserted. Its dead volume, although larger than lithography-based valves, is 
signiﬁcantly lower than that of commercially available stand-alone solutions with 
competitive manufacturing costs. 
Experimental 
Design and Operating Concept: The body of the valve consists of a hollow cylindrical 
core, capped at one end, with a side port (Figure 8). An elastic cylindrical sleeve is 
stretched over the core covering the side port (Figure 8b). When suﬃcient positive 
pressure is applied to the interior of the core, the sleeve expands and allows ﬂow through 
the side port between the exterior of the core and interior of the sleeve. The radially 
oriented pressure out the side port in conjunction with the friction between the sleeve and 
core prevents the sleeve from slipping oﬀ. Once the pressure is reduced, the sleeve 
returns to its resting diameter on the core, closing the port and preventing backﬂow. The 
valve is easily integrated into a system by ﬁtting the open end of the core into the ﬂuid 
path. It can be used in an open conﬁguration, letting ﬂuid ﬂow out into a reservoir, or it 
can be encapsulated to create an in-line check valve (Figure 8c). Similarly functioning 
valve designs have been proposed.
77-79
 However, the non-cylindrical geometries proposed 
in these patents are likely to increase their manufacturing challenges, which is, perhaps, 
the reason these valves are not commercially available. 
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Figure 8: Valve design components: (a) inner rigid core with one end capped and one 
side port; (b) rigid core with elastomeric sleeve covering side port; (c) encapsulated valve 
for in-line use. 
 
The cracking pressure of the herein described valves can be tuned to a desired 
value by adjusting easily controllable valve dimensions. We developed a mathematical 
model for an idealized case, using elasticity theory of thick-walled cylinders, which 
predicts that the cracking pressure of the valve is dependent solely on the modulus of the 
sleeve material, the outer diameter of the core, and the inner diameter and wall thickness 
of the sleeve. Although this model is based on an idealized case, we expect that we can 
create valves with different and tunable cracking pressures by varying the above 
mentioned core and/or sleeve geometries.  
In reality other factors likely contribute to the valve performance, such as small 
adhesive forces and/or friction between the core outer surface and the inner surface of the 
sleeve, and axial deformation of the sleeve. Such additional forces likely contribute to the 
two distinct observable pressures associated with the opening of the valve. First, there is 
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an initial pressure spike indicating the true cracking pressure, where the pressure inside 
the valve core is large enough to stretch the sleeve open, releasing the dead-air trapped 
inside the valve core. We refer to this initial spike as the valve cracking pressure. After 
this initial pressure spike, there is a lower pressure associated with maintaining the valve 
in the open position. We refer to this pressure as the sustained open pressure.  
 
Valve Fabrication: According to our model, the valve cracking pressure depends 
predominantly on the diameters of the core and sleeve, which are made from rigid and 
elastic tubing readily available with precise diameters at low costs. The tolerances on 
other features, such as the geometry of the side port, length of the sleeve, or position of 
the sleeve, depend mainly on additional considerations such as valve seating and method 
of insertion into the final device. The tolerances for these other parameters are larger than 
the needed tolerances for core OD, sleeve ID, and sleeve wall thickness, which simpliﬁes 
valve manufacturing and assembly, since these other features of the valve are 
substantially more expensive to manufacture to the same precision. 
Two different embodiments of the valve were assembled and tested (Figure 9). 
The first valve consisted of a core that was fabricated from stainless steel hypodermic 
tubing (Small Parts, Inc), sliced into short sections using a cutting wheel on a rotary tool. 
We then cut a notch on the side into each core tubing segment to create the side port, and 
sealed one end of each segment with UV curing glue (KOA 300, Kemxert Co.) or with 
melted polycarbonate. The valve sleeve was made from silicone tubing (VWR 
International, LLC), which was pushed over the core, covering the side port. A puﬀ of air 
was injected into the valve to inﬂate the sleeve tubing above the cracking pressure. This 
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relieved any axial deformation that may have occurred while placing the sleeve on the 
core. Excess silicone was cut away with scissors. We fabricated two sets of test valves 
using this method, with alternate dimensions for the core and sleeve (Table 4). 
The second valve embodiment consisted of a core fabricated from PEEK tubing (Zeus 
Inc.), sliced into short segments using a razor blade. We then cut a notch into the side, 
and sealed one end of the core by melting the PEEK material. The valve sleeve was made 
by casting silicone (R 1328, Silpak Inc.) into short cylinders with varying inner diameters 
and wall thicknesses. These sleeves were then pushed over the PEEK core, covering the 
side port. As for the previous design, a puﬀ of air was injected into the valve to relieve 
any axial deformation of the sleeve. We fabricated several sets of test valves with 
constant core dimensions and sleeve wall thickness, but with varying sleeve inner 
diameters (Table 4, Figure 9).  
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Figure 9: Different embodiments of the sleeve valve. (a) Stainless steel core tubing with 
silicone tubing sleeve. (b) PEEK core tubing with cast silicone sleeves, with varying 
sleeve inner diameters, as indicated in the figure. 
 
Table 4: Key dimensions and physical parameters for three valve sets. 
 Stainless Steel Valve Set 1 Stainless Steel Valve Set 2 PEEK Valves 
Core Outer Diameter 
0.065 ± 0.0005"  
(1.65 ± 0.01 mm) 
0.042 ± 0.0005"  
(1.07 ± 0.01 mm) 
0.061 ± 0.0003” 
(1.56 ± 0.007 mm)
c
 
Core Inner Diameter 
0.047 ± 0.0005"  
(1.19 ± 0.01 mm) 
0.027 ± 0.0005" 
(0.69 ± 0.01 mm) 
0.03 ± 0.002” 
(0.76 ± 0.05 mm) 
Sleeve Inner Diameter 
a
 0.058" (1.47 mm) 0.030" (0.76 mm) 
0.047 - 0.057” 
(1.19 - 1.45mm)
d
 
Sleeve Wall Thickness 
a
 0.009" (0.229 mm) 0.018" (0.46 mm) 0.017” (0.43 mm) 
Sleeve axial modulus of 
elasticity
b
 
482 ± 37 PSI 229 ± 19 PSI 79.0 ± 0.1 PSI 
a
 Sleeve inner diameter and wall thickness when sleeve is relaxed. 
b
 Determined experimentally by 
performing a tensile test (Instron ®) with 10 replicates for each sleeve material. 
c
 Measured for actual 
PEEK tubing batch used in valve construction. 
d
 Five valve sets were fabricated with different sleeve inner 
diameters, see Figure 9. 
Valve Testing: Each valve tested was connected to a syringe pump and a ﬂuid ﬁlled 
pressure sensor (Omega Engineering, Inc) via a T-junction. At the outlet, the valve was 
open to atmosphere such that the gauge pressure measured by the sensor represented the 
pressure drop across the valve, which was recorded over time. 
Results and Discussion 
Cracking and Sustained Open Pressures: We determined the cracking and sustained open 
pressures for the stainless steel and PEEK core valves (Table 5). With the syringe pump 
set to a ﬁxed ﬂow rate, the pressure upstream of the valves increased until it reached the 
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cracking pressure. Thereafter, the pressure held steady at the sustained open pressure 
(Figure 10a i and ii, respectively).  
 
Table 5: Cracking and sustained open pressure for different valve sets 
Valve Type
 a
 
Flow rate 
[µL/min] 
Cracking Pressure 
[PSI] 
Sustained Open 
Pressure [PSI] 
Steel set 1 500 6.00 ± 1.38 5.39 ± 0.71 
Steel set 1 200 4.93 ± 1.09 4.74 ± 0.75 
Steel set 2 500 19.89 ± 1.73 19.29 ± 1.77 
PEEK set 1 500 7.41 ± 0.57 4.82 ± 0.30 
PEEK set 2 500 6.64 ± 0.43 3.76 ± 0.22 
PEEK set 3 500 6.22 ± 0.63 3.41 ± 0.20 
PEEK set 4 500 5.31 ± 0.58 2.94 ± 0.19 
PEEK set 5 500 5.24 ± 0.32 2.22 ± 0.80 
PEEK set 6
b
 500 7.81 ± 0.53 6.23 ± 0.50 
PEEK set 6
b
 200 7.83 ± 0.52 6.08 ± 0.71 
PEEK set 6
b
 100 7.00 ± 0.57 5.34 ± 0.83 
a
 Five to ten identically manufactured valves tested per data set.
 b
 PEEK set 6 manufactured using sleeves 
with inner diameter nominally identical to PEEK set 1, but manufactured using a different mold with slight 
differences in other parameters. 
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Figure 10: Cracking and sustained open pressure for different valve embodiments. (a) 
Pressure as a function of time for an example steel valve, indicating (i) cracking pressure 
and (ii) sustained open pressure; (b) Cracking pressure for the two stainless steel valve 
sets; (c) Cracking pressure for PEEK valve sets 1-5, as a function of silicone sleeve inner 
diameter. 
 
All valves tested provided distinct and reproducible cracking and sustained open 
pressures (Table 5, Figure 10), with pressure values ranging from 2 to 20 PSI, depending 
on the valve type. This ability to tune the cracking and sustained open pressures enables 
ready fabrication of valves suitable for different applications. No back ﬂow leakage was 
encountered prior to exceeding the measurement capabilities of the pressure sensor (30 
PSI). Furthermore, the observed trends in cracking pressure agree qualitatively with the 
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trends predicted by the model. Steel valve set 2 has significantly larger cracking and 
sustained open pressure values compared to steel valve set 1, as expected based on the 
larger difference between the core outer and sleeve inner diameters, and the larger sleeve 
wall thickness for set 2. For the PEEK core valves, as predicted by the model, the 
cracking and sustained open pressure decreased as the inner diameter of the sleeve 
increased (Figure 10c). Furthermore, upon decreasing the flow rate from 500 to 200, and 
100 µL/min, the cracking and sustained open pressures for representative steel and PEEK 
valve sets decreased slightly, by up to ~1 PSI (Table 5). 
The cracking versus sustained open pressure was not significantly different for the 
steel valves (p value  0.499), but for the PEEK valves, the cracking pressure was 2.0  
0.8 PSI larger than the sustained open pressure (p value  0.00012). We hypothesize that 
the difference between cracking and sustained open pressure depends primarily on the 
materials used for the sleeve and core, which dictate the adhesion and friction between 
the sleeve and core. The cast silicone sleeves appear to have much stronger adhesive 
interactions with different surfaces, compared to the sleeves obtained from silicone 
tubing. If having a cracking pressure spike is undesirable for a particular application, then 
this can be remedied by choosing different sleeve and / or core materials.  
 
Dead Volume: The dead volume within the valve depends on the internal geometry and 
length of the core. The stainless steel core valves have a dead volume of 15 µL for set 1, 
and 3 µL for set 2. The dead volume of the PEEK core valves was 4 µL. The volume can 
be reduced without changing the cracking pressure or sleeve material by increasing the 
wall thickness of the core, thereby reducing the internal diameter and dead volume. 
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However, reducing the internal diameter of the core increases the overall ﬂow resistance. 
Therefore, the most suitable core ID has to be selected based on the requirements of a 
given application. 
 
Compatibility with Nucleic Acid Amplification: We have incorporated the PEEK core 
valves into our disposable cartridge to execute isothermal nucleic acid amplification 
coupled to lateral flow detection.
62
 For fluidic systems that execute nucleic acid 
amplification, components that come in contact with sample or master-mix fluids should 
be free of the target DNA or RNA, or products of target amplification, to prevent false 
positive amplification. For our prototype development studies, we found that DNA 
contamination can be eliminated by subjecting cartridge components to a dry-autoclave 
cycle for 50 minutes at 120 °C. We dry-autoclaved 8 fully-assembled PEEK core valves, 
and tested their valve cracking and sustained opening pressures before and after 
autoclaving (Table 6). The valve cracking pressure decreases slightly after autoclaving, 
but the difference was not found to be statistically significant (p ≥ 0.13). 
Table 6: Cracking pressure for PEEK valves before and after autoclaving 
Valve Type Autoclaved 
Flow rate 
[µL/min] 
Cracking Pressure 
[PSI] 
PEEK set 1 No 200 6.26 ± 0.83 
PEEK set 1 Yes 200 5.56 ± 0.36 
PEEK set 4 No 200 4.15 ± 0.45 
PEEK set 4 Yes 200 3.69 ± 0.09 
Four valves of each type were tested at a flow rate of 200 µL/min, either in its original form or after dry 
autoclaving for 50 minutes at 121 °C prior to the experiment. The valve cracking pressure decreases 
slightly after autoclaving, but the difference was not found to be statistically significant (p ≥ 0.13). 
Furthermore, these valves come in contact with the master-mix prior to isothermal 
DNA amplification in our system. Therefore, we needed to verify that the valve materials 
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do not inhibit the DNA polymerase mediated amplification in our isothermal Loop 
Mediated Amplification (LAMP) reactions.
38
 For these experiments, we incubated a 
small piece of each valve material, either autoclaved or in its original form, in LAMP 
reaction buffer for 60 minutes at 63 °C, with agitation by rocking at a speed of 750 RPM. 
We then used this buffer solution in setting up LAMP reactions that were subsequently 
amplified in the presence and absence of the targeted genomic DNA by incubation at 
63 °C, with real time fluorescence monitoring using an Opticon2 real-time PCR 
instrument (Bio-rad, Hercules, CA). None of the valve materials inhibited the LAMP 
reactions (Figure 11), and autoclaving did not affect the amplification results. We further 
demonstrated LAMP based DNA amplification in our cartridge configuration including 
the valves,
62
 and the valves functioned in this system as expected (Figure 11). 
 
 
Figure 11: Nucleic acid amplification reactions with (solid lines) and without (dashed 
lines) autoclaved valve materials incubated in the reaction buffer prior to running the 
amplification reaction. The valve materials do not inhibit the reaction. A small piece of 
each valve material, either autoclaved or in its original form, was incubated in LAMP 
reaction buffer for 60 minutes at 63 °C, with agitation. We then used this buffer solution 
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in setting up LAMP reactions that were subsequently amplified in the presence and 
absence of the targeted genomic DNA by incubation at 63 °C, with real time fluorescence 
monitoring using an Opticon2 real-time PCR instrument (Bio-rad, Hercules, CA). Blue: 
LAMP positive reactions containing 3000 copies of target genomic DNA per reaction. 
Red: LAMP negative control reactions, which did not contain target DNA. 
 
Conclusions 
We demonstrated a stand-alone, miniature check valve design with selectable and 
reproducible cracking and sustained open pressures. The axial ﬂow alignment of the 
valve lends itself to be press-ﬁt, or similarly inserted into a ﬂow path. The valves can be 
fabricated in a simple and reproducible manner from readily available, low-cost materials. 
The current prototype production process involves manual cutting, sealing, and notching 
of the rigid core, which alternatively can be accomplished through industry-standard deep 
draw production methods. Likewise, we used casting to generate elastomeric sleeves of 
varying inner diameters, but for mass production, the sleeves can be more readily 
obtained in large volume by injection molding, or by cutting silicone tubing of the 
appropriate inner diameter and wall thickness into shorter pieces. Therefore, the 
production of these valves can be scaled up to large-volumes using traditional 
manufacturing techniques. The valves can be manufactured from non-reactive materials 
that are compatible with challenging applications such as automation of biological 
assays.
62
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CHAPTER 4: REFINED PROTOTYPE FOR AMPLIFICATION AND 
DETECTION SUBUNIT 
Introduction 
The work presented herein builds upon an earlier prototype of the amplification and 
detection unit
80
 (Chapter 2), comprised of a disposable cartridge containing flexible 
pouches, passive valves
63
 (Chapter 3), and electrolysis-driven pumps, in conjunction with 
a small heater. Using this refined subunit, we have demonstrated successful execution of 
an established and clinically-validated isothermal LAMP reaction targeting 
Mycobacterium tuberculosis (M.tb) DNA,
38
 which we have coupled to NALF detection. 
Experimental 
The refined disposable cartridge can execute two isothermal nucleic acid amplification 
reactions coupled to lateral flow detection in parallel. This enables identification of 
multiple targets, or amplification of the target (M.tb) in one reaction and an unrelated 
amplification control in another reaction, which is useful for reactions that cannot be 
readily multiplexed, such as LAMP.  
The operating principle is illustrated in Figure 12a. A sample of purified genomic 
DNA is injected through a septum into the sample input port. The sample is directed into 
a chamber containing liquid or lyophilized master-mix reagents using a syringe pump to 
simulate an upstream integrated electrolytic pump (ePump). Next, the master-mix is 
pumped through a channel with a hydrophobic barrier that vents the dead air that 
originally filled the fluid channels, and into the reaction insert. This reaction insert 
consists of two reaction pouches with inlet and outlet ports containing one-way passive 
check valves. Each reaction pouch is enclosed by a pump pouch connected to an ePump. 
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The reaction insert is located above a heating plate on the instrument, which facilitates 
isothermal amplification at a set temperature for a pre-determined length of time. Once 
amplification is complete, the ePump is turned on. Water electrolysis generates gas that 
pressurizes the fluid in the pump pouch, which then compresses the reaction pouch, 
forcing the amplified master-mix to exit through the outlet valve and into the lateral flow 
detection chamber located on the top of the cartridge. The amplified master-mix migrates 
up the lateral flow strip, generating a positive result if the test and control lines appear 
visible, or a negative result if only the control line appears visible. The lateral flow 
detection chamber is vented into the waste chamber through another hydrophobic barrier 
to reduce pressure build-up as the amplified master-mix is pumped into the chamber. 
Overall, amplification and detection are executed in an automated fashion in a fully-
enclosed cartridge, to prevent amplicon carry-over. 
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Figure 12: (a) Design concept of the fluidic system of the cartridge. (b) CAD design of 
the cartridge components including: (i) cartridge core, (ii) spacer ring, (iii) reaction insert, 
and (iv) bottom casing. (c) Injection molded pieces of the cartridge components. 
 
The cartridge (Figure 12b) consists of a polycarbonate core piece, that 
incorporates two integrated ePumps, fluidic channels, two chambers that hold master-mix 
reagents, and two lateral flow detection chambers. The fluidic channels and lateral flow 
detection chambers are closed via polycarbonate film heat sealed to the top and bottom of 
the core piece. The cartridge also features a polypropylene insert containing reaction and 
pump pouches formed via heat sealing polypropylene film onto the rigid polypropylene 
insert, with check valves press fit into the inlet and outlet ports of the reaction pouch. 
(a)
(b) (c)
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reagents
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ePump
lateral flow strip
pump pouch
vent
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Dead air is removed from the reaction pouches during assembly, and the pump pouches 
are filled with silicone oil that facilitates hydraulic pumping through a connection with 
the ePumps, and enhances heat transfer between the heater surface of the instrument and 
the enclosed reaction chamber. The assembled reaction insert is press fit onto the 
polycarbonate core, which is then attached to another polycarbonate bottom casing. To 
protect the insert-molded electrodes from mechanical shock, the electrode pins are 
recessed within the cartridge by the addition of an acrylic spacer ring that runs along the 
entire seam between the polycarbonate core and bottom casing pieces. The bottom casing 
contains access windows to the reaction pouch insert and ePump electrodes, and presses 
the reaction insert against the core, providing appropriate fluidic seals at the connection 
points. During assembly, the internal volume of the cartridge is filled with silicone foam 
to reduce the heat lost from the reaction insert during isothermal amplification. 
To demonstrate feasibility of scalable production of the proposed cartridge design, 
the polycarbonate cartridge core and bottom casing, as well as the polypropylene reaction 
insert components, were injection molded (Figure 12c). Currently, a maximum of 24 
polycarbonate or 100 polypropylene components can be produced in one workday. By 
improving the mold design and moving the process to an industrial machine with steel 
molds, we estimate that ≥1000 polycarbonate components and a much larger number of 
polypropylene inserts could be produced per day on each dedicated machine. 
 
Handheld Instrument: Complementing the refined disposable cartridge, we also refined 
the prototype instrument to facilitate heating, pumping, and timing. The instrument 
secures the cartridge in a recessed slot on its top surface. Datum location and spring clip 
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mechanisms ensure proper mating of the electrical contacts and the heating surface of the 
instrument to the ePump connectors and the reaction insert on the cartridge (Figure 13). 
The on-board microprocessor can be readily programmed to obtain the required assay 
timing, heater temperature, and current provided to the ePumps, which means that 
different types of isothermal amplification assays can be readily accommodated. This 
refined prototype system operates from a plug-in DC power source, but the low-power 
electronics can be readily operated from an integrated battery pack. The instrument 
contains three LEDs, of which one indicates appropriate heater temperature and two 
indicate proper ePump connections, plus a start button to trigger assay execution. 
 
Figure 13: Steps of cartridge insertion into the designed instrument including (a) insert 
cartridge datum into locator slots in the instrument housing at an angle and (b) lower the 
cartridge into the slot and release the spring loaded clip to secure the cartridge. 
 
Results and Discussion 
Reaction Insert Design: The initial design intent for this refined cartridge was to 
transition all of the polypropylene components and films to polycarbonate, as 
(a) (b)
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polycarbonate is more robust and more commonly used for consumer products.However, 
preliminary studies showed that the double-layered reaction and pump pouch set-up used 
from the previous polypropylene cartridges could not be duplicated using polycarbonate 
film heat-sealed to a rigid polycarbonate body. The polycarbonate film is brittle and does 
not stretch, eliminating the flexible nature of the double-pouch system, which is 
necessary for the simple fluid handling and pumping mechanisms used for this cartridge. 
Therefore, the cartridge design was modified to retain the double-layered polypropylene 
reaction and pump pouch scheme as an independent component that is inserted into the 
polycarbonate cartridge body. 
 
Valving and Fluid Handling within the Reaction Insert: The reaction insert within the 
cartridge needs to receive and contain the master-mix during the amplification process, 
then enable pumping of amplified master-mix onto the lateral flow strips. Fluid handling 
within the reaction insert (Figure 12a) is facilitated via a mechanism similar to a 
diaphragm pump, with a reaction pouch enclosed by a pump pouch, and including 
passive check valves at the inlet and outlet to the reaction pouch. An inlet valve of lower 
opening pressure prevents back flow leakage of the reagents. An outlet valve with higher 
opening pressure ensures proper fluid containment during the reagent injection into the 
reaction pouch and the isothermal amplification period. These check valves have to be 
low-cost and mass-producible, with predictable nominal opening pressures and low dead 
volume. Commercially-available valves do not meet these requirements. Therefore, we 
developed a novel, custom valve design
63
 (Chapter 3) to implement the fluidic control. 
The assembled valves were press fit into the reaction inserts. 
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To characterize the fluidic control of master-mix entering and exiting the reaction 
pouch through these valves, we injected fluid into assembled reaction insert using a 
syringe pump, and monitored the pressure upstream of the inlet port to the reaction pouch. 
We also monitored the pressure in the filled and closed pump pouch as a surrogate for the 
pressure in the reaction pouch. As buffer fills the reaction pouch, no further stretching of 
the polypropylene film covering the reaction or pump pouches is required. However, at 
the beginning of the experiment, the reaction pouch is empty with the reaction pouch film 
pressed up against the dome of the reaction chamber, and the pump pouch is fully-filled. 
As the reaction pouch is filled, a similar volume of pump pouch fluid is forced out of the 
pump pouch outlet and pressurizes the enclosed ePump chamber. Therefore, we can 
assume that the pressure measured at the closed pump pouch outlet approximately 
reflects the pressure in the reaction pouch. For this experiment, four replicates all showed 
similar behavior, an example of which is given in Figure 14. Approximately 30 µL of 
compressible air ahead of the liquid causes slow pressurization at the inlet at the start of 
the pumping. The inlet pressure then increased while the pump pouch pressure remained 
constant at zero, until the opening pressure of the inlet valve was reached. This was 
followed by a pressure drop as the fluid rushed into the reaction pouch. As the reaction 
pouch filled with liquid, the inlet pressure and pump pouch pressure both increased, but 
the difference between the two pressure measurements remained constant at around 4 PSI, 
which is the required pressure to sustain the inlet valve in the open position. Eventually, 
the opening pressure of the outlet valve was reached, and the fluid began to exit into the 
lateral flow detection chambers. The outlet valves opened at around 6 PSI pressure 
difference between the pump pouch / reaction pouch, and open atmosphere. In these four 
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replicates, 250 ± 60 µL of reaction buffer could be pumped into the reaction pouch 
between the opening events at the inlets and outlet valves, which is more than adequate to 
accommodate the desired assay volume of 100 µL per reaction. 
 
Figure 14: Fluidic control of reaction pouch filling. Fluid was pumped into the reaction 
pouch at 3 µL/sec for 91 sec, and then the pump was turned off (grey area). The inlet 
pressure was measured upstream of the inlet valve, in-line with the fluid pumping into the 
reaction pouch. The pump pouch pressure was measured as a surrogate to indicate the 
pressure inside the reaction pouch. (a) Inlet pressure increases, then drops, which 
indicates inlet valve cracking. (b) Inlet and pump pouch pressures build as fluid fills the 
reaction pouch. The outlet valve does not allow fluid to flow out of the reaction chamber. 
The small pressure peak presumably indicates dead air trapped in the reaction pouch 
exiting the chamber through the outlet valve. (c) Maximum peak pressure indicates outlet 
cracking pressure and the point at which fluid begins flowing out of the reaction chamber. 
(d) Inlet pumping was stopped, allowing fluid to exit the reaction chamber and pressure 
inside the reaction pouch to equilibrate. 
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Hydrophobic Barriers and Venting: Proper venting of dead air stuck in the channels 
upstream of the reaction pouch is crucial to achieve reproducible amplification, as large 
gas bubbles introduced into the reaction pouch may interfere with heat transfer and 
temperature equilibration throughout the master-mix volume in the reaction pouch. We 
selected a PTFE porous membrane with 0.2 µm pores on polypropylene mesh backing as 
venting material. This membrane was heat sealed on top of the polycarbonate channels 
immediately upstream of the reaction pouch to be used as a hydrophobic barrier to vent 
the trapped air. 
We characterized the performance of the hydrophobic barrier by injecting 150 µL 
reaction buffer fluid using a syringe pump into the cartridge sample input port and then 
into the reaction insert, while measuring the pressure in the upstream fluid channel 
(Figure 15).  
 
Figure 15: Pressure measurement in the upstream channel during injection of 150 µL 
reaction buffer from the sample inlet port into the reaction insert. (a) The barrier vents the 
dead air ahead of the fluid until the fluid fills the upstream channel. No air is injected into 
the reaction pouch. (b) The venting barrier closes as liquid fills the area underneath the 
barrier. Pressure builds in the upstream fluidic channel until the inlet valve opens. (c) The 
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fluid is pumped into the reaction pouch through the inlet valve. The channel pressurizes 
due to the pressure exerted by the filled and closed pump pouch. (d) After approximately 
100 µL liquid is injected into the reaction pouch, the gas behind the injected volume is 
vented through the venting barrier and the remainder of the volume is trapped in the 
vented portion. No air is injected into the reaction pouch. 
 
This hydrophobic barrier vented the gas in the channels as fluid was pushed from 
the sample inlet port towards the reaction insert without pressure buildup (Figure 15a), 
but became impermeable once the liquid reagents reached the inlet valve of the reaction 
insert. At that point, the pressure increased until the inlet valve cracking pressure was 
reached (Figure 15b). Liquid reagents then entered each reaction pouch and, during this 
process, the pressure further increased because pressure was exerted onto the closed and 
filled pump pouch. However, the venting barrier did not allow fluid to leak out of the 
cartridge during the entire 10 PSI fluid pressure build-up encountered in this process 
(Figure 15c). Once approximately 100 uL of the liquid reagents was injected into each 
reaction pouch, the barrier released the pressurized gas present in the channel upstream of 
the injected volume, effectively stopping the pumping action (Figure 15d), leaving 
approximately 50 uL of reagents in the venting portion of the upstream channel. A thin 
layer of fluid wetted the porous membrane and, therefore, a small pressure in the venting 
channel was required to open the porous membrane. However, the decrease in the 
upstream pressure was sufficient to close the inlet valve and prevent further pumping of 
air into the reaction pouch. 
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Lateral Flow Detection Chambers: For our cartridge design, it is particularly important 
that the lateral flow strip chambers be completely sealed, since the master-mix will have 
been amplified prior to being pumped into the chamber. For this refined amplification 
and detection cartridge, the lateral flow chambers needed to be integrated into the core 
polycarbonate body, requiring the chamber to be sealed with polycarbonate film. 
Previous investigations indicated that lateral flow strip performance can be negatively 
affected if pressure builds inside the lateral flow strip chamber as master-mix is pumped 
in and the air inside the chamber compresses. The polypropylene film used in the 
previous cartridge version (Chapter 2) could stretch to accommodate the increase in 
volume when the amplified master-mix was pumped into the lateral flow strip pouches, 
which is not ideal but proved to be sufficient for initial testing. To mitigate this problem, 
and since the polycarbonate film is less flexible than polypropylene film, we included 
commercially-available hydrophobic barriers (Qosina) to vent air out of the new lateral 
flow chambers, reducing any possible pressure build-up. 
Additionally, the lateral flow strips in the previous amplification and detection 
cartridge design were approximately 1 cm shorter than standard sized strips (typically ~ 5 
cm), and had to be run in anti-parallel orientation to fit within the footprint of the top of 
the cartridge. For this refined amplification and detection subunit, the lateral flow 
chambers were re-designed to fit two full-length strips in parallel orientation. We 
investigated the fluid flow and lateral flow strip performance within chambers of several 
sizes, with varying additional features (Figure 16). One of these additional features was a 
reagent pool area located above the fluid conduit connecting the reaction chamber with 
the lateral flow strip chamber. We manufactured lateral flow strips wtih sample pads that 
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extended into this reagent pool. We observed the best and most reproducible performance 
for lateral flow detection chambers that contained such a recessed reagent pool, which 
ensures that the lateral flow strip performance is not compromised by a rapid outflow of 
fluid from the reaction pouch, and which enables controlled absorption of the amplified 
master-mix into the lateral flow strip, allowing proper reconstitution of the dried reagents. 
Previous studies indicated that if the flow rate into the lateral flow strip chamber is too 
fast, then the fluid will flow around and over the lateral flow strip, instead of wicking 
through and across the nitrocellulose membrane.  
These studies further demonstrated that the hydrophobic barrier needs to be 
recessed below the chamber bottom surface, that the largest chambers tested had the best 
fluid control, and that a pressure point at the interface of the conjugate pad and the 
nitrocellulos is needed for proper fluid flow along the lateral flow strip. This pressure 
point helps to guide the fluid as it wicks from the conjugate pad to the nitrocellulose 
membrane. In the current design, we apply pressure manually as the fluid is pumped from 
the reaction pouch into the lateral flow strip chamber. In future design iterations, however, 
this pressure point will need to be included in the chamber design.  
 
(a)
(b)
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Figure 16: Lateral flow strip chamber testbed. (a) Empty lateral flow strip chambers, 
showing embedded hydrophobic barriers (blue). (b) Lateral flow strip chambers with 
lateral flow strips sealed by polycarbonate film. The red line on the conjugate pads is the 
lateral flow conjugate that has been dispensed and dried onto the conjugate pad. 
 
Electrolytic Pumping: After the amplification reaction is completed, the integrated 
ePumps are used to push the amplified master-mix from the reaction pouch into the 
lateral flow detection chambers. The ePump chambers are filled with electrolyte solution, 
and are connected via a closed channel to the pump pouch port of the reaction insert. By 
applying a constant current to the electrodes in the ePump chambers, hydrogen and 
oxygen gas is generated though water electrolysis. This gas then pressurizes the silicone 
oil which fills the pump pouches. Since the pump pouches are supported from below by 
the instrument surface, the pressure is transferred to the reaction pouch through the 
flexible membrane separating both pouches. Once the outlet valve is opened, the 
membrane pushes the amplified product from the reaction pouch to the lateral flow 
detection chamber, at a flow rate dependent on the characteristics of the outlet valve and 
the pressure built up in the reaction pouch, which in turn is dictated by the rate of gas 
generated by the ePump. If the ePumps generate too much pressure, then the reaction 
pouch contents will be pushed too rapidly onto the lateral flow strips, exceeding the 
capacity of the lateral flow strip sample pad to absorb the liquid and properly reconstitute 
the reagents on the conjugate pad, which may negatively impact the detection readout. 
Our prototype instrument electronics contain controllable current sources to power the 
ePumps, and are capable of generating a constant current with a resolution of 2.7 mA up 
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to 700 mA. The lower end of this current range will be used to power the ePumps in the 
amplification and detection unit. We determined that by applying 8.2 mA or 13.7 mA of 
current to the ePumps, the outlet valve opened within 98 or 57 seconds, respectively, 
from the start of electrolysis. In both cases, the fluid exited the reaction pouch at a flow 
rate of approximately 2-4 uL/s, which is in the required range to enable suitable lateral 
flow performance.  
 
Thermal Control: A constant and controlled temperature throughout the reaction pouch, 
and reproducible heat transfer between the reaction pouch and instrument heater, is 
critical to the performance of this diagnostic system. To facilitate appropriate thermal 
control, the cartridge contains thermal insulation above the reaction insert, and the bottom 
of the reaction insert is designed to protrude below the bottom cartridge surface by 400 
µm. The pump pouches are completely filled with silicone oil and slightly inflated. 
Therefore, the liquid-filled pump pouches enclosing the reaction pouches are pushed up 
against the heater surface, ensuring good thermal contact between the heater and reaction 
pouches.  
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Figure 17: Temperature of the fluid inside the reaction pouch of a cartridge attached to 
the heater as a function of time. The fluid reaches a stable temperature within 
approximately ten minutes.  
 
The combination of these strategies enables efficient heating of the reaction buffer 
within both reaction pouches to the targeted temperature within approximately 10 
minutes (Figure 17). The temperature is maintained at steady-state over the duration of 
the isothermal amplification period. We implemented an established LAMP reaction 
which requires a constant temperature of 63 °C in our cartridge. However, the thermal 
set-point of the heater incorporated in our instrument can be readily adjusted to the 
desired temperature required for different types of isothermal amplification reactions. 
 
Entire Process and Assay Execution: The process consists of the following steps: an 
empty cartridge is attached to the instrument, which is then powered on. At that point, the 
heater LED blinks red to indicate system initialization, and the system performs an 
ePump check: if proper connections between the instrument and ePumps are established, 
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then the two blue ePump LEDs blink three times. The heater LED then turns solid red 
while the heater warms up to the programmed temperature. The heater LED turns solid 
green once the final heater temperature has been reached. At that point, the sample is 
manually injected into the reaction pouch. The master-mix remains in the reaction pouch 
chambers to incubate at the set temperature for the desired reaction time, at which point 
the heater is turned off and the reaction ePumps are turned on. Once suitable pressure is 
acheived within the pump pouches, the fluid in the reaction pouches will be forced 
through the outlet valves and into the lateral flow strip detection chambers.  
  
Figure 18: Demonstration of fluidic process in cartridge on instrument. (a) Cartridge 
attached to instrument, with reaction buffer (colored blue) injected into storage chamber. 
(b) Instrument LEDs indicate function of heater (red LED) and ePumps (blue LEDs). (c) 
Lateral flow detection of reaction buffer spiked with synthetic DNA product pumped out 
of the reaction pouch onto the lateral flow strips in the cartridge. 
 
To demonstrate fluid handling in the cartridge, we injected 150 uL dye-colored 
reaction buffer into each of the two sealed conical storage chambers (Figure 18a). We 
then manually triggered the instrument to start the amplification reaction cycle, and 
pumped the liquid reagents into the reaction pouch by pushing air at a rate of 3 uL/sec 
(a) (b) (c)
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into the two sample inlet ports using a syringe pump. After suitable pressure had been 
reached to open the inlet valve, the reaction buffer moved downstream into each reaction 
pouch of the reaction insert. As the buffer entered the reaction insert, the pumping air 
advanced down the channel until it exited through the venting barrier. The release of 
upstream pressure closed the inlet valves. The injection process was completed in 2 
minutes. This experiment omitted the heating and incubation steps to save time and, after 
the sample was injected, the instrument was triggered to apply 13.7mA of current to the 
ePumps for 2 minutes, indicated by the ePump LEDs turning solid blue (Figure 18b). 
Within approximately 1 minute, sufficient pressure was reached in the pump pouches to 
open the outlet valves, and the contents of the reaction pouches were pushed into the 
lateral flow detection chambers in less than one minute. We also executed the process 
using uncolored reaction buffer spiked with a synthetic amplification product that can be 
detected on the lateral flow strip to verify that the cartridge enables a suitable visual 
readout (Figure 18c). 
We then conducted an initial proof of principle experiment to demonstrate that a 
LAMP reaction can be executed successfully in the cartridge. This reaction is based on a 
published method to detect the gyrB gene within M.tb genomic DNA,
38
 which we have 
modified to enable coupling to NALF
80
 (Chapter 2). To verify proper amplicon formation, 
our first experiment utilized gel electrophoresis rather than lateral flow detection. As 
described above, we turned on the instrument and attached an empty cartridge to the 
handheld unit, allowing at least 10 minutes for the heater and cartridge to reach 
appropriate reaction temperature. We then injected LAMP master-mix with 3000 copies 
of M.tb genomic DNA per reaction into the reaction pouches and allowed the reaction to 
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incubate for 60 minutes. After incubation, amplified master-mix was withdrawn from the 
cartridge and analyzed via gel electrophoresis (Figure 19). Both reaction pouches 
generated the expected ladder of high molecular weight concatenated amplicons typical 
for LAMP, with banding patterns similar to control reactions that were performed in 
standard reaction tubes. 
 
Figure 19: Detection of M.tb genomic DNA through 60 minutes of isothermal LAMP in 
the cartridge on the instrument, verified via gel electrophoresis of amplified master-mix 
removed from the cartridge after the reaction. Amplified product from both reaction 
pouches (lanes 3 and 4) generated a similar pattern as the positive control reactions 
performed in tubes on a standard heater (lanes 5 and 6), indicating that desired 
amplification had occurred in the cartridge. All positive reactions contained 3000 copies 
M.tb genomic DNA. No products were generated in negative control reactions (lanes 7 
and 8) that did not contain M.tb DNA. Lane 1 contained 1 kb molecular weight ladder 
and lane 2 was empty. 
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We have modified the lateral flow configuration from the previously reported 
configuration 
80
 (Chapter 2) to rely on hapten-only interactions on both the test and 
controls lines. In this new configuration, neutravidin and rabbit anti-sheep antibody are 
immobilized onto the nitrocellulose for the test and control lines, respectively. A 
polyclonal digoxygenin antibody (anti-DIG) from sheep is conjugated to colored 
microspheres and will bind to the DIG-labeled BIP primer if the amplicon product is 
present in the sample. Additionally, the neutravidin that is immobilized on the 
nitrocellulose strip will bind to the biotinylated FIP primer if the amplicon product is 
present, resulting in a visual line in the test area. The rabbit anti-sheep antibody present at 
the control area binds the anti-Dig conjugate and will be present regardless of the 
presence of LAMP amplicon. 
 Initial studies using LAMP master-mix with 3000 copies of M.tb genomic DNA 
in positive samples have demonstrated proper automated fluid handling from sample 
insertion through lateral flow detection on board the cartridge. However, these initial 
positives samples did not show amplification on the lateral flow strips. We have 
identified possible causes for the lack of amplification. First, all prior studies were 
conducted with cartridges that had been manufactured in dirty lab conditions. While we 
were able to demonstrate amplification, there was a risk that these cartridges had been 
contaminated during manufacturing. We have since transitioned all cartridge 
manufacturing processes into clean lab conditions (Appendix G). Under these new 
conditions, the thermal bonding for all fluid conduits on the cartridge is performed in a 
laminar flow hood. When running the initial amplification and detection assays in these 
clean cartridges, we noticed the pump pouches showed leakages. It is possible that the air 
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blowing over the heated arbor press in the laminar flow hood is preventing the arbor 
press from reaching the necessary temperature to provide sufficient thermal bonding. In 
addition, this arbor press may not consistently have even contact across the heated die 
and the cartridge surfaces, yielding one edge of the thermal bond ineffective. We are 
currently investigating strategies to mitigate this issue. 
 Moreover, the previous studies demonstrating amplification in the cartridges were 
performed by bypassing the upstream fluidic channels and chambers leading into the 
reaction pouch. For these studies, the LAMP master-mix was injected directly into the 
reaction pouches. For the current studies, the master-mix is now injected through the 
sample port, exposing the reaction mixture to a higher amount of plastic surface area in 
the upstream channels and chambers. We had demonstrated polycarbonate assay 
compatibility in earlier studies, but noted that these cartridges had been exposed to UV 
radiation while the insert-molded electrodes in the polycarbonate core were secured in 
place with UV glue. We then tested the irradiated polycarbonate for possible inhibition, 
but none was observed.  
Finally, in our work with the initial cartridge prototype (Chapter 2), we observed 
that the cartridges required higher concentrations of BSA in the master-mix as compared 
to standard reaction tubes (Appendix F). We hypothesize that this increase in BSA 
concentration is necessary to mitigate non-specific adsorption of enzyme to the plastic 
surfaces in the cartridges. Therefore, with the increase in plastic surface area from the 
upstream fluidic channels and chambers in this refined cartridge prototype, we will 
investigate increasing the BSA concentration in the master-mix to possibly passivate 
these surfaces.  
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Conclusions 
We refined the amplification and detection prototype cartridge and instrument to perform 
the necessary fluidic and thermal control operations for automated isothermal nucleic 
acid amplification coupled to visual lateral flow detection. The system utilizes 
economical and scalable manufacturing techniques as a step toward point-of-care 
infectious disease diagnosis in low-resource settings. Additionally, we developed and 
implemented in this cartridge low cost fluidic components such as passive valves, 
electrolytic pumps, and hydrophobic vents. We have characterized and verified 
appropriate performance of the key fluid handling and thermal control components, have 
demonstrated that the system can execute the entire process sequence, and, in a 
preliminary experiment, have demonstrated the detection of 3000 copies of purified M.tb 
genomic DNA via isothermal LAMP amplification using this disposable cartridge and 
instrument. We have transferred the cartridge manufacturing to a clean environment to 
mitigate contamination risk, and have manufactured 10 cartridges in this environment. 
Preliminary tests have revealed technical issues with these cartridges, which we are 
currently addressing. We anticipate these issues will be resolved soon, rendering the 
refined amplification and detection subunit fully-functional. 
  
68 
 
CHAPTER 5: REAGENT STORAGE AND RECONSTITUTION 
Introduction 
Point of care diagnostics intended for low-resource settings must be suitably designed for 
the targeted use environment. For example, many health care facilities in low-resource 
countries lack un-interrupted access to electricity, making reagent refrigeration 
impossible. Moreover, distribution to remote health care facilities cannot rely on cold-
chain transportation, since this infrastructure is nonexistent in the majority of these 
settings. Therefore, reagents need to be incorporated in the device in a stabilized form to 
withstand prolonged exposure to ambient and above ambient temperatures. Additionally, 
health care workers at these facilities have minimal training, and lack the required tools 
to precisely measure and combine reagents. Therefore, reagents need to be aliquoted and 
stored on-board the disposable cartridges. 
 Different reagent stabilization approaches for nucleic acid testing systems have 
been reported. In settings where refrigeration is available, master-mix reagents can be 
stored in reagent packs or pre-measured on-board cassettes in reservoirs or pouches.
33,81
 
Lyophilization of master-mix reagents for recombinase polymerase amplification (RPA), 
82
 and LAMP,
82,83
 plus commercially-available PCR beads (Illustra “PuRe Taq Ready-
To-Go PCR beads,” GE Healthcare, Piscataway, NJ),84 have been demonstrated as a 
viable stabilization method. In most cases, excipients are added to the reagents to aid in 
preservation, such as trehalose, a protein-stabilizer. Additionally, to ensure proper 
consistency of the lyophilized material, a bulking agent, such as dextran, is often added. 
However, lyophilization of master-mix reagents cannot be performed on regular 
laboratory lyophilizers used to prepare purified peptides and proteins for storage. Master-
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mix lyophilization requires large systems with temperature-controlled reagent trays and 
programmable temperature and time ramps. Lyophilized pellets need to be generated with 
suitable consistency to enable manipulation. While this has been done, it is not trivial. 
Lyophilized pellets are very hydroscopic and often hard to handle, which complicates 
their integration into a final device. 
 Alternate reagent stabilization approaches have been developed, often with the 
addition of trehalose.
85
 Other groups have reported using heat to stabilize reagents in 
microfluidic devices by drying at 37 C86 or at 55 C.87 Kiviniemi et al. have reported 
using a combination of vacuum- and air-drying to stabilize PCR reagents.
88
 Paraffin-
passivation is another method of stabilizing reagents on-board microfluidic chips, in 
which reagents are added during assembly and then encapsulated in paraffin wax.
89
 
Glassification
90
 is another method of reagent stabilization used in commercial products 
which includes the addition of a glass-forming filler material, such as glucose, sucrose, 
maltose or maltotriose, to produce material that is stable at room temperature using 
freeze-drying
91,92
 or vacuum-drying.
93
 
During use, master-mix reagents in liquid, lyophilized, or dried form need to be 
reconstituted and combined with purified DNA present in the sample preparation eluate 
to yield the final master-mix. Effective mixing of master-mix reagents before nucleic acid 
amplification is important, because reaction kinetics are affected by reagent 
concentrations. Assay performance may thereby be negatively affected if the reagent 
concentrations vary within a reaction volume due to improper mixing. Active mixing of 
master-mix components in cartridges designed for nucleic acid testing has been reported 
using plungers (Cepheid GenXpert) and pistons (Rheonix CARD), but these approaches 
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require additional hardware, thereby increasing the system cost and complexity. Passive 
mixing by diffusion is a viable option if the diffusion length is held to a minimum and the 
reaction volume can be contained in a single chamber for a set period of time to allow for 
diffusive mixing to reach the final equilibrium. 
 The refined amplification and detection cartridge described in Chapter 4 was 
designed to hold a lyophilized master-mix pellet in a conical chamber (Figure 20). We 
generated lyophilized LAMP reagent pellets suitable for integration into this chamber in 
collaboration with, and using the state-of-the-art lyophilization equipment at, the Program 
for Appropriate Technology in Health (PATH, Seattle, WA). These pellets produced 
promising amplification results when reconstituted and amplified in standard PCR tubes. 
However, on the cartridge, we found that the reconstitution process did not enable 
uniform and effective mixing. The cartridge design assumes that the eluate from the 
sample preparation module is pumped into the conical chamber, where it re-hydrates the 
master-mix pellet. After incubating the liquid in this chamber for a suitable time to ensure 
uniform passive mixing, the final reaction mixture would be pumped into the reaction 
pouch. In reality, the initial fluid front entering the conical chamber was quickly wicked 
into the pellet, drawing a small volume out of the upstream fluid channel and introducing 
an air bubble into the fluid path (Figure 20b). This air bubble prevented the reaction fluid 
from mixing as one continuous volume. Subsequent pumping to move the liquid out of 
the conical chamber led to the initial fluid front containing highly concentrated 
reconstituted reagents exiting first (Figure 20(ii)), followed by an air bubble, and a 
second volume with much lower reagent concentration (Figure 20b(i)). Although the air 
bubble can be removed through the hydrophobic barrier, the liquid entering the reaction 
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pouch was not well mixed, which would compromise controlled isothermal amplification. 
This lack of fluid control and mixing when reconstituting the master-mix reagents made 
this lyophilized pellet and conical reconstitution chamber embodiment incompatible with 
our cartridge design. 
 
Figure 20: Lyophilized pellet storage and reconstitution chamber as originally designed. 
(a) Reconstitution of pellet (red arrow) in blue colored water. (b) Depiction of 
reconstitution, illustrating the pellet wicking the initial fluid front to the bottom of conical 
chamber and pumping further downstream, while introducing an air bubble in the fluid 
stream separating the initial fluid front (ii) from the remaining fluid (i). 
 
As previously discussed, our ultimate goal is to develop a fully-integrated system 
that performs sample preparation, amplification, and detection. The work described in 
this thesis pertains to the module for nucleic acid amplification and detection, developed 
at KGI. In a parallel effort, Claremont BioSolutions has developed a disposable cartridge 
and electronics instrument system for sample preparation and nucleic acid extraction. The 
next step toward our overall project goal is to combine these two separate cartridges into 
one fully-integrated, sample-in to answer-out cartridge. In this fully-integrated cartridge, 
the eluate exiting the upstream sample preparation subunit needs to reconstitute the 
stabilized master-mix reagents before it can be pumped into the downstream reaction 
pouch chamber for isothermal amplification. Ensuring the function of this fluidic 
(a) (b) i
ii
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interface between the sample preparation and amplification and detection modules is 
critical for the overall project effort. Therefore, we decided to develop and demonstrate 
suitable performance of a reagent storage and reconstitution method within a separate 
fluidic module, designed to act as the interface between the sample preparation module, 
and the amplification and detection module (Figure 21).  
 
Figure 21: Original system overview diagram. Red area highlights the fluidics interface 
between sample preparation and amplification and detection, which needs to store 
stabilized master-mix reagents until they can be reconstituted by purified sample 
preparation eluate and pumped into the reaction pouch chamber. The initial design 
incorporated lyophilization to stabilize the master-mix reagents. 
 
System Overview 
The goal for the fluidic interface module is two-fold: (1) to provide a mechanism for 
storing dry master-mix reagents in a stabilized form, and (2) to provide a mechanism by 
which master-mix reagents can be reconstituted with purified sample preparation eluate, 
resulting in a homogeneous master-mix which then can be pumped downstream into the 
reaction pouch.  
The fluidic interface module design is based on a novel reagent stabilization 
approach, utilizing master-mix reagents lyophilized onto a microfiber material. This 
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material, in the form of a thin filter paper, was incorporated inside an elliptical fluid 
chamber, with an inlet and outlet conduit at the respective ends (Figure 22). Purified 
sample preparation eluate is pumped into the chamber through the inlet, first absorbing 
into the microfiber material containing dried master-mix reagents and then filling the 
chamber completely. The pumping is stopped, to allow the master-mix reagents to diffuse 
into the fluid. The master-mix is then pumped through the outlet, past a hydrophobic 
venting barrier and through a one-way valve into the reaction pouch chamber where 
amplification is initiated. 
 
Figure 22: Fluidic system overview. (a) Top view: purified sample enters the chamber, 
first absorbing into the lyophilized master-mix material matrix, and then filling the 
chamber completely. (b) Side view: after a short incubation period to allow the reagents 
to diffuse, the reconstituted reaction master-mix is pumped through the outlet.  
 
Experimental 
Fabrication: All testbeds were manufactured from solid pieces of polycarbonate plastic. 
Using a CNC mill, we machined elliptical chambers (5 – 11.5 mm wide, 7.5 – 15 mm 
length, .5 – 1 mm depth), in some cases containing additional internal features, with 
through holes at the ends of the ellipse serving as inlet and outlet conduits. Microbore 
tubing (polyvinyl chloride, 0.5 – 1 mm inner diameter, 1.5 – 1.8 mm outer diameter) was 
press-fit into the inlet and outlet fluid conduits (Figure 23). Some chambers contained 
additional fluid conduits and features, as discussed below. The reconstitution chambers 
inlet outlet
(a)
inlet outlet
(b)
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and all additional fluid conduits on all testbed embodiments were sealed closed using 
PCR film. 
 We integrated a refined venting chamber into this fluidics interface module to 
expel any dead air trapped in the fluid channels prior to introducing the master-mix into 
the reaction chamber. Early testbed embodiments (Figure 24) utilized commercially-
available hydrophobic barriers (Qosina), while the final refined version incorporated 
custom venting barriers manufactured from a polypropylene-backed PTFE filter 
membrane, previously described in Chapter 4. When using custom venting barriers, the 
filter membrane was heat-sealed onto the polycarbonate testbed using the heated arbor 
press. For the refined design (Figure 25), the outlet of the reconstitution chamber is 
connected to the inlet of the venting chamber via a fluid channel on the underside of the 
testbed. The outlet of the venting chamber is connected to the polypropylene reaction 
insert through a boss that protrudes from the underside of the testbed.  
 
Fluidics Testing of Microfiber Materials: We tested several possible microfiber materials 
as a matrix onto which the master-mix reagents can be dried (Table 7). Using the testbed 
embodiment shown in Figure 23(a), a piece of microfiber material cut into the 
appropriate elliptical shape was placed in each chamber, which was then sealed closed 
using PCR film. We determined the volume of unrecoverable fluid inside the chamber 
containing the microfiber material in the following manner: a liquid plug of ~ 150 µL 
was injected using a syringe into the inlet tubing upstream of the reaction chamber. The 
specific volume of fluid was determined by measuring the length of the fluid plug in the 
inlet tubing, and then calculating the total volume using the inner diameter of the tubing. 
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The liquid plug was then manually pushed into the reconstitution chamber, where it was 
incubated for ~ 1 min. The fluid was then manually pushed out of the chamber and into 
the outlet tubing, at a flow rate of approximately 100 µL / min. The amount of fluid 
recovered from the reaction chamber was determined again by measuring the length of 
the fluid plug in the outlet tubing, and then calculating the volume based on the inner 
diameter of the tubing. 
Table 7: Key dimensions and physical parameters for support materials. 
Product Name 
Material Typical Thickness 
(µm) 
Water Absorption 
(mg/cm
2
) 
CF1
a
 
100% cotton linter, 
light, thin grade 
175 ± 26 
16 
GF/A
b
 Unbound glass microfiber 271 98 
CF3
a
 
100% cotton linter, 
medium weight 
335 ± 49 
31 
Fusion 5
 a
 
Proprietary FUSION material, 
single-layer matrix 
350 ± 40 
40 
a
 GE Healthcare. 
b
 Whatman, a division of GE Healthcare.
 
 
 
Stabilizing Master-Mix Reagents: The reagent stabilization studies presented herein 
focused on developing a dry master-mix formulation for the LAMP M.tb assay discussed 
in Chapters 2 and 4. Elliptical pieces of microfiber material were pre-treated by dipping 
them into a solution containing 2 % trehalose and 0.4 mg/mL BSA. The pieces were then 
placed inside standard 1.5 mL tubes, and were allowed to dry overnight at ambient 
temperature. 
Next, ~ 30 µL of master-mix reagents (5X concentrated) were then pipetted onto 
the pretreated pads inside the 1.5 mL tubes. The tubes were then placed inside a Savant 
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Speed Vac Concentrator, which was attached to a Labconco Freeze Dry System/Freezone 
4.5. During the drying process, the rotor of the Speed Vac containing the samples was 
spun at 1300-1600 RPM, while the Labconco lyophilizer was pulling a vacuum of ~ 0.1 
torr, with the cooling coil inside the lyophilizer set to - 40 C. 
The 5X concentrated master-mix solution contained 2 % trehalose and other 
standard reaction buffer components (Tris, KCl, (NH4)2SO4). For initial studies, only one 
of the more sensitive master-mix reagents (primer oligonucleotides, dNTPs and Bst 
polymerase) was added to the concentrated master-mix at a time. For reconstitution, the 
remaining LAMP master-mix reagents that were not included in the drying process were 
combined into a 150 µL volume. The microfiber pieces containing the dried reagents 
were incubated in this reconstitution volume in a 1.5 mL tube, to enable the dried master-
mix reagents to be released from the microfiber matrix. After incubating, the fluid was 
withdrawn from the tube and transferred to standard PCR tubes, followed by isothermal 
amplification on a Bio-Rad OpticonII real-time fluorescence PCR thermocycler, set to a 
constant temperature of 63 C. 
Results and Discussion 
Reconstitution Chamber Design: The reconstitution chamber shape was designed to 
enable uniform filling of the chamber with incoming liquid, and to maximize fluid 
recovery out of the chamber after the master-mix reagents have reconstituted. There are 
two main mechanisms that prevent fluid from being recovered from the reconstitution 
chamber when air is pumped into the chamber: (1) fluid can be left behind in “free space” 
once the air has navigated a path from the inlet to the outlet of the chamber, and (2) fluid 
can be retained inside the microfiber material matrix. 
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We selected an eliptical chamber shape approximately 11 mm wide, 15 mm long, 
and 1 mm deep, which provided a sufficiently large internal volume, and enabled 
reasonably uniform fluid filling and emptying due to the absence of sharp features. Based 
on related discussions with microfluidics experts, we investigated internal features for the 
reconstitution chamber, such as pillars and chevrons, to facilitate fluid mixing and to trap 
any air bubbles formed in the chamber (Figure 23). However, initial studies determined 
that sharp edges and/or topographical features inside the chamber lead to non-uniform 
chamber filling as well as the introduction of air bubbles and large dead volumes that 
could not be recovered when the fluid was pumped out of the chamber. Therefore, all 
future experiments were performed without additional structures within the chamber.  
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Figure 23: Investigation of different reconstitution chamber geometries. For each case, 
showing (i) empty chamber, (ii) partially filled chamber, and (iii) chamber after as much 
fluid could be emptied as possible. (a) Ellipse without any structures. (b) Ellipse with 
structure in front of outlet intended to catch any air trapped in the chamber. (c) Ellipse 
with chevron structures intended to enhance mixing in the chamber. (d) Ellipse with 
cylindrical pillars intended to enhance mixing in the chamber. All structures inhibited 
(a)
(b)
(c)
(d)
(i) (ii) (iii)
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emptying of the chambers, leaving large dead volumes of unrecoverable fluid in the 
chambers. The empty ellipse shape (a) had the largest fluid recovery. 
 
We observed that, even for the chambers without internal features, when 
emptying the chambers with an air chase, the amount of fluid left behind was 
irreproducible. As soon as the air pushed into the chamber behind the liquid found a path 
to the outlet, all remaining fluid in the chamber was unrecoverable. We hypothesize that 
this behavior is related to the properties of the chamber geometry and the inclusion of the 
cotton microfiber material into the reconstitution chamber. The Hele-Shaw cell is a well-
characterized model investigating viscous fluid confined between closely spaced parallel 
sheets of glass. Experiments have shown that instability develops at the interface between 
fluids of different densities, resulting in round-ended “fingers” of less dense fluid 
penetrating the more dense fluid.
94-96
 If we assume that the reconstitution chamber can be 
modeled as a Hele-Shaw cell, this would explain the “fingering” seen in the empty 
chamber experiments where the air finds a path from the inlet to the outlet, leaving 
unrecoverable fluid in the chamber. Additionally, Hele-Shaw would suggest that there 
will always be unrecoverable fluid in the empty chamber. 
However, introducing the cotton microfiber pad into the reconstitution chamber 
disrupts this system in such a way that the “finger” mechanism is no longer the driving 
force. Experiments have shown that, as the surface-tension affects become more 
important, the “finger” widens to fill the channel.97 Focusing on the reconstitution 
chamber shown here, the cotton pad is more hydrophilic than the polycarbonate in the 
empty chamber case. Therefore, with the inclusion of the cotton pad, the surface tension 
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between the water above and the water inside the cotton pad becomes significant, 
resulting in the incoming air “finger” widening to expel all the water in the space above 
the cotton pad. 
 
Volume Requirements: In our cartridge design (Chapters 2 and 4), a minimum of 75 – 
100 µL of amplified master-mix needs to be pushed out of the reaction chamber and onto 
the lateral flow strips to ensure optimal performance, since we do not employ a separate 
lateral flow strip running buffer. This volume serves as the minimum required amount of 
fluid that needs to be recovered from the reaction pouch chambers. Accounting for 
additional dead volumes in the valves and fluid conduits leading into and out of the 
reaction chamber range (~ 10 uL), and the dead volume underneath the hydrophobic 
venting barrier ( ~ 25 uL in the refined design), we can estimate approximately 50 µL of 
reaction fluid lost in the fluid conduits downstream from the reconstitution chamber. 
Therefore, we need to recover ~ 150 µL of reconstituted master-mix from the 
reconstitution chamber to ensure proper performance of downstream processes.  
The original fully-integrated cartridge design entailed splitting the purified sample 
preparation eluate into two reaction chambers. Assuming no fluid losses in the 
reconsititution chamber, this would require at least 300 µL of sample preparation eluate. 
Initial studies have indicated that the sample preparation module comfortably can yield ~ 
200 µL eluate, but 300 µL would be very difficult to obtain reproducibly. It further is 
unrealistic to assume no fluid losses in the reconstitution chamber. For this and other 
reasons related to overall size, cost, and complexity, we recently decided to simplify the 
fully-integrated cartridge system to contain only one reaction chamber. Therefore, if 150 
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µL can be recovered out of the reagent reconstitution chamber after pumping in ~ 200 µL 
of purified sample preparation eluate, a loss of 25% (50 µL ) of input volume can be 
tolerated. The studies on the fluidic module shown here were performed using 150 µL for 
the input volume, based on the original splitting design. Additionally, master-mix 
reconstitution in the reagent chamber should ideally be performed in batch mode, 
meaning that the entire volume of eluate (originally 150 µL, for future studies 200 µL) is 
introduced into the chamber at one time, and can be incubated above the pad to facilitate 
uniform reconstitution of the dried reagents, and diffusive mixing within the relatively 
short vertical distance above the pad. 
 
Fluid Recovery: As previously described, fluid recovery depends on the amount of fluid 
left behind in “free space”, as discussed in a previous section, and fluid retained inside 
the microfiber material matrix. For optimal fluid recovery, the microfiber matrix should 
absorb only a small amount of liquid. However, the microfiber material needs to be able 
to retain the necessary volume of reaction master-mix reagents during the drying process: 
30 µL of 5X master-mix, assuming a total volume of 150 µL, or 40 µL of 5X master-mix, 
assuming a total volume of 200 µL. The requirements for fluid recovery when the 
reconstituted master-mix is pushed out of the chamber, and fluid retention of master-mix 
during drying have to be balanced against each other. 
All of the microfiber materials were tested to determine the unrecoverable fluid 
lost in the material when approximately 150 µL reaction buffer was pumped into the 
reconstitution chamber, followed by approximately 700 µL of air (Table 8). The amount 
and percentage of unrecoverable fluid appears to depend on the material properties, and 
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was most favorable for the two cotton based materials, CF1 and CF3, with a higher 
recovery for the thinner CF1 pad. The Fusion 5 and GF/A microfiber materials had the 
highest unrecoverable volumes. The CF1 material was chosen for future studies. 
Table 8: Average fluid loss for each microfiber material 
Product Name Average Fluid Loss (µL) Average Fluid Loss (%) 
CF1 25 15 
GF/A 55 35 
CF3 41 24 
Fusion 5
 
 67 47 
 
Venting Chamber: After reconstitution, the fluid leaving the chamber must pass a 
hydrophobic barrier to vent the dead air, thereby minimizing the amount air that is 
introduced into the reaction pouch. The original amplification and detection subunit 
design included a commercially-available hydrophobic barrier (Qosina) as a venting 
barrier, which we integrated into an early testbed designed to test the venting mechanism 
(Figure 24a). We demonstrated that trapped dead air could be vented through this barrier. 
However, once the microfiber material was added into the reconstitution chamber (Figure 
24b), the unrecoverable volume increased dramatically, which is undesirable. Therefore, 
a new venting chamber was designed. 
 In previous studies (Chapter 4), we verified that a polypropylene-backed PTFE 
membrane could be heat-sealed onto polycarbonate fluid channels to create a 
hydrophobic barrier that vents air through the top seal.
62
 Utilizing this design, we 
integrated the hydrophobic barrier on the top of a separate venting chamber, which was 
added downstream of the reconstitution chamber (Figure 24c). We heat-sealed the 
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polypropylene-backed PTFE membrane around the perimeter of the venting chamber, 
and were able to demonstrate that all dead air was removed, and that the fluid exited the 
venting chamber as one complete bolus.  
 
Figure 24: Reconstitution chambers with integrated venting barriers. (a) Reconstitution 
chamber with commercially-available hydrophobic barrier integrated into chamber. (b) 
Reconstitution chamber with integrated hydrophobic barrier and microfiber material, 
which had a higher percentage of fluid that could not be recovered from this chamber 
design. (c) Polypropylene-backed PTFE membrane material heat-sealed to an isolated 
venting chamber downstream of the reconstitution chamber. 
 
Initial Fluidics Testing: We designed a final testbed to demonstrate that the fluidics 
module containing the reconstitution and venting chambers could interface directly with 
the polypropylene reaction insert (Figure 25). Since the current polypropylene inserts 
contain two reaction pouches per insert, the testbed was designed with two reconstitution 
and venting chamber sets, enabling duplicate fluidic tests per testbed. This testbed 
contained protruding bosses on the underside of the polycarbonate to mate the outlets of 
each venting chamber with the female luer-type fluid conduit on the inlets of the 
polypropylene reaction insert. The integrity of the liquid-tight seal was tested by inserting 
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the boss into the polypropylene insert, and pumping fluid through the fluid conduit 
interface. We demonstrated that, while the conduit interface was not air-tight, it did not 
leak any fluid, making it appropriate for continuing forward with integration studies. 
We further demonstrated appropriate fluid handling in the testbed using a CF1 microfiber 
pad onto with food coloring was dried, to visualize the reconstitution process. 
Approximately 150 µL of water was pumped into the reconstitution chamber, and the 
pumping was stopped when the chamber was full. The fluid was allowed to incubate for 
~ 2 minutes above the pad, reconstituting most of the dried food coloring. After 
incubating, air was pumped into the reconstitution chamber, pushing the fluid through the 
venting chamber, to release any dead air, and then into a reaction pouch through a one-
way, passive valve. The testbed performed as expected, with the fluid reconstituting the 
food coloring and the reaction pouch filled with colored water without air bubbles 
(Figure 25). 
 
(a) (b)
(c) (d)
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Figure 25: Fluidic interface testbed demonstrating the reconstitution of dried food 
coloring. (a) Top side of fluidic interface testbed showing one of the two fluidic module 
testbeds, including the venting chamber (white) and the reconstitution chamber, with 
orange food coloring dried onto the CF1 microfiber material. (b) Reconstitution chamber 
filled and reconstituting the orange food coloring, with fluid beginning to pump through 
the fluid conduit on the underside of the testbed from the reconstitution chamber to the 
venting chamber. (c) Bottom side of fluidic interface testbed, showing polypropylene 
reaction insert with empty reaction and pump pouches. (d) Reaction pouch with orange 
colored water inside after reconstituting the food coloring and pumping through the one-
way valve into the reaction pouch chamber. 
 
Reagent Stabilization: Our reagent stabilization approach used a modified lyophilization 
process has not been previously reported, and we are continuing to optimize this protocol. 
Current studies are focusing on drying the LAMP reagents onto the microfiber material.  
We have dried the primer oligonucleotides and the dNTPs individually, and in 
combination with each other, on the CF1 microfiber material. We were able to 
demonstrate amplification upon reconstitution (Figure 26). Amplification of negative 
samples does occur and is most likely due to amplicon contamination during the drying 
process. We are continuing to optimize the drying protocol to improve reconstitution 
performance. 
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Figure 26: Reconstitution of dried LAMP master-mix reagents. Black solid line is 
reconstituted LAMP master-mix spiked with M.tb genomic DNA (positive). Black 
dashed line is reconstituted LAMP master-mix without M.tb genomic DNA (negative). 
Amplification of negative sample is most likely due to lab amplicon contamination 
affecting the reagent drying process. 
 
 Additionally, we reconstituted the dried master-mix material in the fluidic testbed 
to demonstrate amplification of reconstituted materials in the polypropylene reaction 
pouch insert (Chapter 4) on the original handheld heater instrument (Chapter 2). The 
reconstituted material was incubated in a reaction pouch insert on the handheld heater for 
one hour, and was then withdrawn via syringe to verify amplification through gel 
electrophoresis (Figure 27). As shown in Figure 27: Amplification of reconstituted 
master-mix materials. (a) Amplification results from two samples reconstituted in the 
fluidics testbed, with M.tb genomic DNA spiked into the reconstitution buffer. Testbed 
#1 shows amplification while Testbed #2 does not. (b) Amplification results from 
samples reconstituted in standard tubes and amplified on a bench-top thermocycler. The 
reconstituted NTC sample did not contain M.tb genomic DNA but does show 
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amplification, likely due to amplicon contamination of lab areas.Figure 27a, one of the 
reconstituted samples showed amplification on the gel similar to the reconstitution 
control reactions which were reconstituted in standard tubes and amplified on the bench-
top thermocycler. These initial reconstitution results are promising, and we are 
continuing to optimize the reconstitution process in the fluidic testbed. Figure 27b shows 
the amplification of samples reconstituted in standard tubes, with both the positive and 
negative reactions indicating clear amplicon product. Most likely the amplification of the 
negative reaction is due to lab contamination of amplicon product, and we are working 
toward setting up a clean work area to improve the drying protocol and to reduce false 
positive reconstitution results. 
 
Figure 27: Amplification of reconstituted master-mix materials. (a) Amplification results 
from two samples reconstituted in the fluidics testbed, with M.tb genomic DNA spiked 
(a) (b)
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into the reconstitution buffer. Testbed #1 shows amplification while Testbed #2 does not. 
(b) Amplification results from samples reconstituted in standard tubes and amplified on a 
bench-top thermocycler. The reconstituted NTC sample did not contain M.tb genomic 
DNA but does show amplification, likely due to amplicon contamination of lab areas.  
Conclusions 
We developed a novel reagent storage and reconstitution module to serve as the interface 
between the sample preparation subunit and the amplification and detection subunit in 
our fully-integrated disposable cartridge. This module will replace the original conical 
reconstitution chamber design from our previous amplification and detection cartridge 
(Chapter 4).  
We have designed the new reconstitution chamber to be a shallow ellipse shape, 
to maximize passive reagent mixing by diffusion. This chamber was designed to interface 
directly the polypropylene reaction insert, and we were able to demonstrate successful 
fluid handling in this module. We have demonstrated the ability to dry LAMP master-mix 
reagents onto microfiber material, and the initial amplification results of samples 
reconstituted in the fluidic testbed are promising. We are continuing to optimize the 
drying process, to improve reconstitution amplification kinetics and to reduce false 
positive amplification of negative samples. Our goal is to demonstrate reconstitution of 
the dried master-mix material by the sample preparation eluate, followed by amplification 
and detection in the fully-integrated cartridge.  
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APPENDIX 
APPENDIX A: MANUSCRIPT SUBMISSIONS 
At the time of submission of this thesis, most of the content of Chapter 2 was submitted 
as a manuscript to the journal PLOS One. KGI has also filed a patent application covering 
the design of this cartridge (System and Method for Efficient Nucleic Acid Testing, US 
patent application number 13/860,453 filed April 10, 2013).
98
  
The work presented in Chapter 3 was submitted as a manuscript to the journal 
Sensors and Actuators, A. Keck Graduate Institute has filed a provisional patent 
application covering the design of this valve (Check Valve, US provisional patent 
application number 61/621,989 filed April 9, 2012).
99
  
The work presented in Chapter 4 was published as a paper in the SPIE Conference 
Proceedings.
62
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APPENDIX B: TEAM ORGANIZATION 
The work presented in this thesis is part of a highly collaborative team effort involving 
other scientists and engineers at Keck Graduate Institute as well as external collaborators. 
Included below is an organization chart, illustrating the primary personnel in the key 
subsystems that make up the project as a whole. My specific contributions are included as 
part of the list of the KGI teams working on each sub-project. 
 
 
 
  
Principal Investigator: Angelika 
Niemz
Goal: Develop a fully-integrated NAAT device to 
diagnose infectious diseases, such as TB, at the 
point of care in low-resource settings 
Assay Development:
KGI, external collaborators
Device Development:
KGI, external collaborators
Sample Preparation
Nucleic Acid 
Amplification
Lateral Flow 
Detection
Sample Prep 
Module
Amplification and 
Detection Module
Integrated System
University of 
Washington
Seattle Biomed
Claremont BioSolutions
PATH
Seattle King County
KGI
Claremont BioSolutions
KGI: Kristina Roskos
KGI: Supriya Kadam 
Eric Houghton 
Kristina Roskos
Claremont BioSolutions KGI: Anna Hickerson
Kristina Roskos
Hsiang-Wei Lu
Claremont BioSolutions
KGI: Anna Hickerson
Kristina Roskos
Hsiang-Wei Lu
91 
 
APPENDIX C: PRODUCT REQUIREMENT MATRIX 
At the beginning of this project, the team developed extensive product requirements with 
maximum and minimum acceptance criteria. After the project had begun, the conference 
entitled Diagnostics Innovation in China: Bring Chinese TB and HIV Molecular 
Diagnostics to Market (Shanghai, September 25-26, 2012) distributed a target product 
profile (TPP), detailing the expectations for TB diagnostics in development. A group of 
Master of BioScience (MBS)  students, along with conversations with our lab team, 
compared our team’s product requirements document with that of the TPP, resulting in 
the product requirement matrix as included on the next page. Furthermore, they added 
columns to demonstrate how these requirements are being met by our current, simple 
system, how they will be met with our future, expanded system, and defined the 
benchmark for performance. 
 
  
 
 
Description 
Max Specification Min Specification 
Success Criteria TPP
1
 Success Criteria TPP
1
 
Cost of goods and 
manufacturing for 
cartridge 
<$10 <$4 <$10 <$8 
Cost of Device <$100 <$5,000 <$1000 <$10,000 
Diagnostic 
sensitivity: smear 
positive  
 ≥ 99 %   ≥ 98 %   ≥ 97 %   ≥ 95 %  
Diagnostic 
sensitivity: smear 
negative  
 ≥ 70 %   ≥ 80 %   ≥ 50 %   ≥ 65 %  
Diagnostic 
specificity 
 ≥ 99 %   ≥ 99 %   ≥ 90 %   ≥ 97 %  
Testing Menu 
TB diagnosis and Rif 
testing in same cartridge 
Detection of rifampicin, 
isoniazid, and 
fluoroquinolone 
resistance testing via a 
separate cartridge with 
additional consumable 
cost 
TB diagnosis only 
Detection of rifampicin, resistance testing via a 
separate cartridge with additional consumable 
cost 
Clinical sensitivity 
(rifampicin 
resistance): smear 
positive  
 ≥ 95 %     ≥ 90 %    
Clinical specificity 
(rifampicin 
resistance) 
 ≥ 95 %     ≥ 90 %    
Overall limit of 
detection/analytical 
sensitivity 
 150 CFU / mL sputum  10
2
 CFU / mL sputum 300 CFU / mL sputum  10
3
 CFU / mL sputum 
Analytical 
specificity 
False Positive Rate: 0 % 
No cross reactivity with 
other organisms including 
non-tuberculosis 
mycobacteria (NTM) 
False Positive Rate: 5 % 
No cross reactivity with other organisms including 
non-tuberculosis mycobacteria (NTM) 
9
2
 
  
 
Description 
Max Specification Min Specification  
Success Criteria TPP
1
 Success Criteria TPP
1
 
Reagent kit stability 
Stable for ≥ 12 month at 
RT, for 1 month at 45°, 
failure rate < 5% at 
expiration, and 
withstands transport at 
≤0°C 
24 months at 40°C, 70% 
humidity, includes 
transport stress (48 hours 
at 50°C) 
Stable for ≥ 12 month at 4°, 
for 1 month at 25°, failure 
rate < 10% at expiration, 
and withstands transport at 
≤0°C 
12 months at 30°C, 70% humidity, includes 
transport stress (48 hours at 50°C) 
Thermal tolerance 
of platform/assay 
N/A 
Operation between 15°C 
and 40°C 
N/A Operation between 15°C and 35°C 
Reagent Integration 
All reagents on board, 
possibly one external 
liquefying reagent 
All reagents in 
consumable 
Reagent addition to 
cartridge for alpha 
prototype 
<4 external reagents 
Sample preparation 
and assay 
processing 
3 steps: (1) sample intro, 
(2) push go, (3) record 
result 
Integrated 
one manual step after 
initiation, (step 2) upon 
timer sounding  
Minimal sample processing; no more than 3-5 
steps (requiring operator intervention) 
User interface 
Intuitive user interface, 
minimum # of buttons 
right on device - 
microprocessor 
Simple test menu, 
integrated LCD screen; 
simple key pad or touch 
screen 
Intuitive user interface on 
external laptop connected 
to device - external control 
Simple test menu, integrated LCD screen; simple 
key pad or touch screen 
Electronics and 
data analysis 
Entire unit is a handheld 
device (requires 
microprocessor) 
Integrated 
Alpha prototype unit is a 
handheld device, with small 
external computer 
Separate computer required 
Portability 
Handheld device (<0.9 
kg) (requires 
microprocessor); l+w+h = 
25 cm 
Small, portable device (<2 
kg) or handheld analyzer 
Alpha prototype unit is a 
handheld device (<2.7 kg), 
with small external 
computer, l+w+h = 50 cm 
Small, table-top analyzer (<5 kg) or portable 
device 
Cold Chain 
No refrigeration needed 
for cartridge, device 
withstands transport at 
≤0°C 
None required at any 
point in supply chain or 
storage 
For alpha prototype some 
reagents require 
refrigeration, with path 
towards stable formulation 
None required at any point in supply chain or 
storage 
Time - to - result 
≤5 min hands-on time 
concentrated at the front 
end; results in ≤ 40min 
from sample introduction 
<1h 
≤15 min hands-on time 
concentrated at the front 
end, results in ≤ 1h from 
sample introduction 
<2h 
Throughput - 
> 48 samples per day, 
asynchronously 
- 12 tests per 8-hour day 
9
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Description 
Max Specification Min Specification 
Success Criteria TPP
1
 Success Criteria TPP
1
 
Biosafety 
Cartridge needs to be 
autoclaved 
No need for biosafety 
cabinet and direct 
disposal of consumable 
Cartridge needs to be 
autoclaved 
No need for biosafety cabinet and autoclaved 
consumable 
Power 
Device runs on 6V, can 
use four AA or AAA 
batteries, rechargeable 
unit (solar power), 10 
runs per charge 
None, optimal battery or 
solar operation 
Device runs on 9V, can use 
one regular 9V battery, 
rechargeable unit (line 
power), 5 runs per charge 
110-220 AC current; DC power with rechargeable 
battery lasting up to 8 hours of testing 
Result capturing & 
documentation/ 
data display 
- 
Electronic and printed; 
wireless transmission 
capabilities 
- Electronic 
Training & 
educational needs 
- 
< 1/2 day for healthcare 
workers 
- < 1 day for trained laboratory technician 
Data Export - 
Data export over mobile 
phone network utilizing 
File Transfer Protocol 
(FTP) every 6-12 hours. 
Should comply with HL7 
standards and have the 
ability to track shifts or 
trends 
- Data export over mobile phone 
Waste/disposal 
requirements 
- 
Incineration of infectious 
disease material; trash for 
everything else 
- 
Incineration of infectious disease material; 
recyclable, compostable, or consumables for 
everything else 
Duration of valid 
sample 
- 
2 hours without 
refrigeration 
- 
sequentially - 5 min                                                         
batching without random access - 2 hours 
9
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Description Final version 1 (simple system) Final version 2 (expanded system) Benchmark 
Cost of Device $170, plus $30 markup (18%) 
<$5000 for four module unit with LF 
reader, connectivity 
Cepheid GeneXpert: $17k per 4 module instrument 
ExWorks, which boils down to COGM of $13k
2
 
Diagnostic sensitivity: 
smear positive  
 ≥ 95 %   ≥ 95 %  Cepheid GeneXpert: 98.3%
3,4
 
Diagnostic sensitivity: 
smear negative  
 ≥ 65 %   ≥ 65 %  Cepheid GeneXpert: 76.9%
3,4
 
Diagnostic specificity  ≥ 97 %   ≥ 97 %  Cepheid GeneXpert: 99.0%
3,4
 
Testing Menu TB diagnosis only 
Detection of rifampicin, resistance 
testing via a separate cartridge with 
additional consumable cost 
  
Clinical sensitivity 
(rifampicin resistance): 
smear positive  
N/A  ≥ 95 %  
Cepheid GeneXpert: 94.1%
3,4
,                              
Line Probe: 93-98.9%
5,6
 
Clinical specificity 
(rifampicin resistance) 
N/A  ≥ 97 %  
Cepheid GeneXpert: 97%
3,4
,                                  
 Line Probe: 99.4-100.0%
5,6
 
Overall limit of 
detection/analytical 
sensitivity 
 10
3
 CFU / mL sputum  10
3
 CFU / mL sputum 
Cepheid GeneXpert: overall LOD 131 CFU/mL, assay 
LOD 4.5 genomes/rxn
8
 
Analytical specificity 
No cross reactivity with other organisms 
including non-tuberculosis mycobacteria 
(NTM) 
No cross reactivity with other 
organisms including non-tuberculosis 
mycobacteria (NTM) 
  
Reagent kit stability 
Stable for ≥ 12 month at 4°, for 1 month at 
25°, failure rate < 10% at expiration, and 
withstands transport at ≤0°C 
12 months at 30°C, 70% humidity, 
includes transport stress (48 hours at 
50°C) 
The Xpert MTB/RIF cartridges and reagents should 
be stored at 2-28°C
8
 
Thermal tolerance of 
platform/assay 
Operation between 15°C and 40°C Operation between 15°C and 40°C 
Cepheid GeneXpert: operation between 2°C and 
30°C
3
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Description Final version 1 (simple system) Final version 2 (expanded system) Benchmark 
Reagent Integration 
wash, elution buffer, master-mix, and LF 
strips in cartridge, liquefying/disinfecting 
reagent and binding buffer part of sample 
collection device 
wash, elution buffer,  master-mix , 
and LF strips in cartridge, 
liquefying/disinfecting reagent and 
binding buffer part of sample 
collection device 
Cepheid GeneXpert: reagent addition to cartridge
3
 
Sample preparation and 
assay processing 
Sputum produced into cup, release 
liquefying / disinfecting reagent, shake, 
incubate 10 min, via syringe add glycine 
buffer, aspirate sample, inject into cartridge, 
push go 
Sputum produced into cup, release 
liquefying / disinfecting reagent, 
shake, incubate 10 min, via syringe 
add glycine buffer, aspirate sample, 
inject into cartridge, push go 
Cepheid GeneXpert: 3 hands-on steps
3
 
User interface 
Simple test menu, integrated LCD screen; 
simple key pad or touch screen 
Simple test menu, integrated LCD 
screen; simple key pad or touch 
screen 
  
Electronics and data  
analysis 
Integrated Integrated 
Cepheid GeneXpert: instrument, computer, and 
barcode wand reader
8
 
Portability 
Small, portable device (<2 kg) or handheld 
analyzer  
Small, table-top analyzer (<5 kg) or 
portable device 
Cepheid GeneXpert: table-top, l+w+h = 79 cm 
Cold Chain 
For alpha prototype some reagents require 
refrigeration, with path towards stable 
formulation 
None required at any point in supply 
chain or storage 
  
Time - to - result <1h <1h Cepheid GeneXpert: <2h
3
 
Throughput 
6 tests per 8h day, for single instrument run 
in series 
24 tests per 8h day, random access Cepheid GeneXpert: 1, 4, or 16 samples in parallel 
Biosafety 
No need for biosafety cabinet and direct 
disposal of consumable 
No need for biosafety cabinet and 
direct disposal of consumable 
Cepheid GeneXpert: same as smear microscopy
3
 
Power 
rechargeable battery lasting up to 8 hours of 
testing 
rechargeable battery lasting up to 8 
hours of testing 
  
9
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Description Final version 1 (simple system) Final version 2 (expanded system) Benchmark 
Result capturing & 
documentation/ 
data display 
simple visual lateral flow readout 
Electronic - LF reader; wireless 
transmission capabilities 
  
Training & educational 
needs 
< 1/2 day for healthcare workers < 1/2 day for healthcare workers 
Cepheid GeneXpert: 2 days for non-experienced lab-
techs
3
 
Service/ 
Maintenance/ 
Calibration 
No annually scheduled preventative 
maintenance required 
No annually scheduled preventative 
maintenance required 
Cepheid GeneXpert: annual calibration. General 
warranty is 12 months
7
 
    
device has capability to send an alert 
or to be detected remotely when it is 
not functioning properly 
  
  
Mean time to failure of at least 12 months; 
18 months preferred 
Mean time to failure of at least 12 
months; 18 months preferred 
  
   No calibration required No calibration required   
Regulatory Requirements 
preliminary document control system, 
DHF/DMR, risk analysis, minimal quality  
Must be produced according to 
cGMPs, ISO 13485 and authorized by 
GHTF 
  
Data Export   
Data export over mobile phone 
network utilizing File Transfer 
Protocol (FTP) every 6-12 hours. 
Should comply with HL7 standards 
and have the ability to track shifts or 
trends 
  
Waste/disposal 
requirements 
Incineration or trash for everything Incineration or trash for everything 
Cepheid GeneXpert: additional waste compared to 
smear microscopy
3
 
Duration of valid sample   2 hours without refrigeration 
Cepheid GeneXpert: start the test within 30 min of 
adding the sample to the cartridge
8
 
9
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APPENDIX D: CARTRIDGE MANUFACTURING STANDARD OPERATING 
PROCEDURE 
To ensure quality and reproducibility of cartridge assembly, I compiled the following 
standard operating procedure (SOP). This SOP is considered to be a working document, 
stored in the shared lab resource folder with all team members having access. The SOP is 
included in its entirety below. The Niemz Lab is developing SOPs for all components and 
processes to assure quality.  
 
   
 
DESCRIPTION: Assembly protocol for manufacturing Amplification and Detection Cartridge version 1 for either EXPAR-LF or LAMP-LF. 
PURPOSE: 
 This SOP details the assembly protocol for manufacturing cartridges. 
MATERIALS 
      
     Keck Graduate Institute: Niemz lab 
SOP-0012 
Rev. date 
09/11/12 
Standard Operating Procedure:  Amplification and Detection Cartridge 
Version 1 Assembly  
Rev. 01 
KR 
Item  
No. 
Source Part No. Item Description Unit Qty. 
 
Lot  No/ 
Prep date  
Quantity 
Used 
  1 
Lee Co. CCPI2510 
014S D 
Check valve, 2.5mm  
 2 
  2 Qosina 49005 Injection Port with Al Cap   2 
  3 Qosina 11628 8” x 10” Autoclave Bag    
  4 
McMaster- 
Carr 
 Silicone rubber cord  
 2 x 1/8” 
slice 
  5 
McMaster- 
Carr 
 Silicone Foam  
 ~2 sq.in 
  6  KGI  Injection molded PP top card   1 
  7 KGI  Injection molded PP bottom card   1 
  8 KGI  Dry reagent LF strips   2 
  9  KGI  1M Na2SO4 electrolyte solution   ~3 mL 
 10   18G needle tip (as electrode)   4 
 11   21.5G needle tip   2 
 12   1 mL syringe   2 
 13   3 mL syringe   1 
1
0
0
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GENERAL NOTES: RECEIVING MATERIALS/COMPONENTS 
--------------------------------------------------------------------------------------------------------------------- 
A. Off-the-shelf components 
1. Lee Company Check Valves 
a) Prepare valves upon receipt by autoclaving in glass beaker (covered with foil) 
for 50 minutes followed by 15 minutes drying. 
b) Once autoclaved, valves should be stored in a clean, dry Ziploc bag inside the 
laminar flow hood in the clean assembly lab. 
c) Use tweezers to handle valves in clean assembly room. 
2. Qosina Injection Ports 
a) Upon receipt, Qosina box should be opened in hallway outside of clean 
assembly lab. Only inner bag containing injection ports should be brought 
inside clean assembly lab. 
b) Store sealed bag in cabinet under laminar flow hood work area in clean 
assembly lab. 
c) Use clean, gloved hands to handle injection ports. 
3. Qosina Autoclave Bags 
a) Upon receipt, Qosina box should be opened in hallway outside of clean 
assembly lab. Only inner bag containing autoclave bags should be brought 
inside clean assembly lab. 
b) Store sealed bag in cabinet under laminar flow hood work area in clean 
assembly lab. 
c) Use clean, gloved hands to handle autoclave bags. 
4. McMaster-Carr Silicone Rubber Cord 
a) Prepare septa by cutting cord into 1/16” thick slices upon receipt. 
b) Decontaminate septa by autoclaving in glass beaker (covered with foil) for 50 
minutes followed by 15 minutes drying. 
c) Once autoclaved, valves should be stored in a clean, dry Ziploc bag inside the 
laminar flow hood in the clean assembly lab. 
d) Use tweezers to handle septa in clean assembly room. 
5. McMaster-Carr Silicone Foam 
a) Upon receipt, Qosina box should be opened in hallway outside of clean 
assembly lab. Foam may or may not be packaged in another inner bag. Only 
foam should be brought inside the clean assembly lab. 
b) Store foam in drawer under laminar flow hood work area in clean assembly 
lab. 
c) Use clean, gloved hands to handle autoclave bags. 
      6. Additional Tools for Assembly 
a)   When possible, all tools used for assembly should be autoclaved for 50 
minutes followed by drying for 15 minutes prior to being brought into the clean 
assembly room. 
b)   If autoclaving is not possible, tools should be decontaminated with 10% 
bleach solution prior to being brought into the clean assembly room. 
B. Raw materials for manufacturing components in-house 
1. Polypropylene Pellets for Injection Molding 
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a) Upon receipt, store box containing pellets under injection molding bench, 
keeping pellets as cool and dry as possible. 
b) While injection molding, use smaller box on bench to refill Morgan Press 
barrel. 
2. Dry Reagent Lateral Flow Strips 
a) Upon receipt, store in clean assembly room. 
METHODOLOGY 
--------------------------------------------------------------------------------------------------------------------- 
A. Preparing Injection molded polypropylene cartridge halves 
1. Drilling top (lateral flow) half – in Prototype Lab 
d) Drill holes through card for the pump chambers (2) using 0.213” drill bit. 
e) Drill holes through card for the reaction pouch inlets/outlets (4 total) using 
0.067” drill bit. 
f) Trim fly from all holes such that there are no sharp points protruding from the 
flat surface of the PP card. 
g) Trim residual PP splay (result of injection molding pieces, may vary in 
amount) from corners of card to ensure card fits into heater plate area. 
2. Drilling bottom (reaction/pump) half – in Prototype Lab 
a) Drill holes through card for the pump chambers (2) using 0.128” drill bit. 
b) Drill holes through card for the reaction pouch inlets/outlets (4 total) using 
0.067” drill bit. 
c) Trim fly from all holes such that there are no sharp points protruding from the 
flat surface of the PP card. 
d) Trim residual PP splay (result of injection molding pieces, may vary in 
amount) from corners of card to ensure card fits into heater plate area. 
3. Autoclave – in Autoclave Room / Clean Assembly Lab 
a) Once polypropylene pieces are drilled, place in dedicated autoclave bin and 
cover with foil. 
b) Dry-autoclave for 50 minutes followed by 15 minutes drying. 
c) After autoclaving, bring bin directly into clean assembly lab and store in 
Ziploc bag until use. 
 
B. Heat-Sealing pouches  
1. Bottom half – in Clean Assembly Lab 
a) Cut polypropylene autoclave bags into 1.5” strips, and then cut strips into 
thirds and separate making PP film pieces. 
b) Using one PP film piece, seal reaction pouches onto one polypropylene 
injection molded/drilled bottom half using heated arbor press set to 350°F 
with reaction pouch version 1 stamp attached. 
c) Trim excess PP film around reaction pouch seams using X-acto knife. 
d) Using one PP film piece, seal pump pouches onto polypropylene bottom half 
using heated arbor press with pump pouch version 1 stamp attached (and 
previous heat setting). 
e) Trim excess PP film around pump pouch seams. 
2. Top half – in Clean Assembly Lab 
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a) Place to one 4mm lateral flow strip into each lateral flow strip groove in one 
polypropylene injection molded/drilled top half, in anti-parallel orientation 
with dry reagent conjugate pads over reaction pouch outlet tubing. 
b) Using one PP film piece, seal lateral flow pouches onto polypropylene top 
half using heated arbor press with lateral flow pouch version 1 stamp attached 
(and previous heat setting). 
c) Trim excess PP film around lateral flow pouch seams. 
C. Valve and septa components 
1. Prepare components – in Autoclave Room / Clean Assembly Room 
a)   Place components into a glass beaker and into dedicated autoclave bin. Cover 
with foil. 
b)   Dry-autoclave for 50 minutes followed by 15 minutes drying. 
c)   After autoclaving, bring bin and beaker directly into clean assembly lab and 
store in Ziploc bag until use. 
2. Insert Valves – in Clean Assembly Lab 
a)   Start with one bottom PP card that has reaction and pump pouches already 
stamped. 
b)   Use tweezers to insert one valve in each of the outlet tubings (two total per PP 
card), with larger, ribbed side of valve on the reaction pouch side of the tubing. 
c)   Use hex key / allen wrench to press-fit valves into place. 
3. Insert Septa – in Clean Assembly Lab 
a)   Start with one top PP card that has lateral flow strip pouches already stamped. 
b)   Use tweezers to insert one septum in each of the inlet tubings (two total per 
PP card). 
c)   Use hex key / allen wrench to press-fit septa into place. 
D. Joining polypropylene halves - in Clean Assembly Room 
1. Plug in hot glue gun and have one top and one bottom PP card ready for assembly 
(pouches stamped and trimmed, with valves/septa/ LF strips already inserted). 
2. Once glue gun is ready, deposit glue around inner faces of all fluid conduits 
(reaction and pump pouch tubings and bosses). 
3.  Press fit top and bottom PP cards together. 
4. Deposit glue around outer faces of all fluid conduits. 
E. Insulating foam - in Clean Assembly Room 
1. Cut large foam sheet to size for cartridges – 2 ¼” x 1 ½” 
2. Cut each smaller piece into four parts. 
3. Keep pieces with cartridge, to be assembled inside cartridge after electrolytic 
chambers have been filled and cartridge is ready to be placed on heater unit. 
F. Adding and filling electrolyte chambers - in Clean Assembly Room 
1. Take two Qosina injection ports per cartridge. 
2. Insert on port into each pump chamber fluid conduit and press fit until chamber 
cannot turn in place. 
G. Individually bag each cartridge 
1. Place on assembled cartridge and one set of four foam pieces into a small Ziploc 
bag. 
2. Each cartridge will remain individually bagged until taken out just before running 
on heater unit.    
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APPENDIX E: FAILURE MODE AND EFFECTS ANALYSIS 
A group of MBS students, along with conversations with our lab team, prepared a Failure 
Mode and Effects Analysis (FMEA) to consider how individual sub-components of this 
overall project can fail. For each failure mode, the severity (S), occurrence (O), and 
detection level (D) were assessed, along with controls that are currently being 
implemented to mitigate risk. Lastly, a risk priority number (RPN) was assigned to 
indicate failure modes, and ultimately system sub-components, which carry the highest 
risk. 
I participated in the FMEA analysis related to the cartridges, including 
amplification and detection cartridge components, reagent storage and the amplification 
and detection assays as performed on the cartridge. The FMEA document is included 
below in its entirety.  
 
  
 
Risk Estimation and Evaluation Risk Control 
C
o
m
p
o
n
en
t 
Function 
Failure 
Mode 
Failure Effect S 
Cause of 
Failure 
Mode 
O 
Current 
Controls 
D RPN 
Mitigation 
Strategy 
S* O* D* RPN* 
OmniValve 
Direct liquids into 
appropriate 
chambers using a 
turning 
mechanism to 
execute duty 
Valve 
turned to 
incorrect 
angle 
Sample cannot be 
introduced into 
cartridge, cartridge 
will not function  
4 
Stepper motor 
miss-alignment 
6 
valve 
homing 
step, but no 
feedback 
2 48 Valve position check 4 3 2 24 
Sample introduced 
into incorrect 
cartridge 
6 
Stepper motor 
miss-alignment 
3 
Valve 
homing 
step, but no 
feedback 
2 36 Valve position check 6 2 2 24 
Valve 
clogged 
Sample cannot be 
introduced into 
cartridge, cartridge 
will not function 
4 
Thick sputum 
mixes with 
beads to form a 
paste 
4 
Keep motor 
running to 
ensure no 
paste settles 
2 32 
Add excess TSP to 
further liquefy sample 
4 2 2 16 
Valve stuck 
Sample cannot be 
introduced into 
cartridge, cartridge 
will not function 
4 
Periods of 
inactivity 
causes sticking 
2 
Manually 
turn valve 
prior to 
sample 
injection 
2 16 
Use lubricant to prime 
the valve 
4 1 2 8 
Overheat and burn 
up motor, cartridge 
will not function 
6 
Periods of 
inactivity 
causes sticking 
2 
Manually 
turn valve 
prior to 
sample 
injection 
2 24 
Use lubricant to prime 
the valve 
6 1 2 12 
 
 
 
 
1
0
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Risk Estimation and Evaluation Risk Control 
C
o
m
p
o
n
en
t 
Function Failure Mode Failure Effect S 
Cause of 
Failure 
Mode 
O 
Current 
Controls 
D RPN 
Mitigation 
Strategy 
S* O* D* RPN* 
OmniValve 
Separation of 
liquid and dry 
reagents while 
stored 
Dry reagents 
exposed to 
moisture 
Reagents and LF 
strips inactive 
6 
Valve not 
perfectly 
sealed 
5 none 5 150 
Implement seal on 
OmniValve 
6 3 5 90 
Reagent 
paper pad 
Contain reagents 
in stable form 
Inhomogeneous 
master-mix 
Potential false 
negative 
9 
Reagents not 
uniformly 
released  
 
Amplification 
kinetics 
inconsistent 
5 None 10 450 
Internal 
Amplification 
Control 
 
Monitor release of 
reagents 
9 5 3 135 
Master-mix 
reagents not 
released 
False negative 9 
No reagents, 
no 
amplification 
4 None 10 360 
Internal 
Amplification 
Control, Detect 
release of reagents 
9 4 3 108 
Master-mix 
reagents are 
dead – i.e. not 
thermostable 
False negative 9 
Inactive 
reagents, no 
amplification 
4 None 10 360 
Internal 
Amplification 
Control 
9 4 3 108 
Sample 
collector 
device and 
TSP/PVI 
treatment 
Contain sample, 
Liquefy and 
disinfect sputum 
Sample not 
disinfected 
Biohazard risk – 
infectious 
mycobacteria 
may be released 
10 Too little PVI 3 None 10 300 
Metering of sputum 
put in an excess of 
PVI 
10 1 5 50 
Sample not 
liquefied 
Too viscous, 
cannot be 
processed 
5 Too little TSP 3 
Gauge 
viscosity of 
sample 
5 75 
Metering of sputum 
put in an excess of 
TSP 
5 1 5 25 
 
 
1
0
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Risk Estimation and Evaluation Risk Control 
C
o
m
p
o
n
en
t 
Function 
Failure 
Mode 
Failure Effect S 
Cause of 
Failure 
Mode 
O 
Current 
Controls 
D RPN 
Mitigation 
Strategy 
S* O* D* RPN* 
Electrolytic 
pumps 
#1 Pump wash 
through 
ominvalve 
 
#2 Fill elution 
into valve 
 
#3 Pump elution 
out of valve into 
reagent chamber 
 
#3 Pump 
reagents into rxn 
chamber 
 
#4&5 Pump 
amplified 
master-mix onto 
LF strips 
Pump loses 
pressure, 
liquid is not 
transferred 
Test fails – no 
result 
7 
Electrolytes are 
not touching, 
no voltage 
applied, no 
flow of 
reagents 
6 
Visual 
inspection 
7 294 
Internal feedback 
system 
 
Manually run current 
through system 
before testing to 
ensure electrolytes 
are connecting 
7 3 3 63 
Test fails – no 
result 
7 
Failure at 
interconnect 
between PP 
insert and PC 
core 
5 
Visual 
inspection 
7 287 
Better pressure 
applied to connect 
insert – locking 
mechanism 
Screws closer to 
insert 
7 3 7 147 
False negative 
due to inhibitors 
carried through 
10 
Inefficient 
washing, too 
much back 
pressure during 
that step, due 
to beads 
settling in 
chamber 
6 
Visual 
inspection 
8 480 
Keep motor running 
at 6V between 
sample introductions 
and washing so 
beads don’t settle. 
Internal 
amplification control 
10 2 1 20 
  
1
0
7
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APPENDIX F: ROOT CAUSE FAILURE ANALYSIS 
The work presented in this thesis utilized root cause failure analysis to identify causes of 
unexpected results, categorized as “failures” because something did not perform as 
expected. The details of all of the experimental set ups and root cause failure analysis are 
not included in this thesis. 
One example where I employed root cause failure analysis is when my initial 
amplification and detection experiments performed in pouches on the initial cartridge 
prototype yielded unusually high false negative results, even after very long incubation 
periods on the heater unit (> 60 minutes). Previous experiments demonstrated EXPAR 
amplification in pouches on the heater unit, with fluid withdrawn from the pouches to 
verify amplification via external lateral flow. However, once the amplification pouches 
and lateral flow detection chambers were integrated into the initial cartridge prototype, 
the reactions were not amplifying. 
The original hypothesis was that the reaction failures were due to improper 
thermal control of the handheld heater unit or heat conductivity from the heater plate into 
the reaction fluid was not sufficient. Thermal testing confirmed the heater surface was 
reaching appropriate assay temperature; therefore, improper heater temperature control 
was eliminated as a possible source of failure. Cartridges were also run in a temperature-
controlled water bath, with the same false negative results after > 60 minutes of 
incubation, indicating that improper temperature conductivity into the reaction fluid 
inside the reaction pouches was also not causing the false negative results. All of the 
cartridge and pouch materials were tested for assay compatibility without any issues, 
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signifying that there were no inhibitors leeching from these materials were that could be 
the source of the false negative results. 
During discussion of these false negative results, Hsiang-Wei explained how, in 
his previous work involving microfluidic PCR chips, his team added BSA into the PCR 
master-mix reagents to pacify the chip surfaces and prevent enzymes from adhering to 
the fluid channels. A concentration of 1.6mg/mL BSA was chosen based on unrelated 
DOE studies performed by previous lab member Jose Salazar demonstrating the assay 
performance was unaffected by the inclusion of BSA. Immediately after incorporating 
BSA into the cartridge reactions, amplification was restored, with detection of product 
after 30 minutes of incubation on the heater unit. Therefore, it was concluded that BSA 
needed to be included into the reaction master-mix in order to pacify the plastic surface 
area. The inclusion of BSA has become a requirement for all isothermal assays performed 
on the cartridges, based on this root cause failure analysis. 
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APPENDIX G: TRANSFER TO CLEAN MANUFACTURING 
One major concern for developing a nucleic acid amplification diagnostic is the risk of 
amplicon carry-over contamination. Since the target sequence is exponentially amplified, 
any breach in containment can leak amplicon product into the environment, leading to 
false positive results in subsequent tests. Therefore, it is imperative that manufacturing 
processes are performed under clean environmental conditions without any amplicon 
contamination in order to ensure proper test results. 
 While developing the initial amplification and detection prototype subunit, we 
identified contamination in our manufacturing areas despite our best efforts at amplicon 
containment. Swab test results indicated that the fluid conduits between the top and 
bottom cards of the initial cartridge prototype leaked amplicon product. Also, all 
cartridge components showed amplicon contamination prior to assembly into cartridges, 
indicating that the manufacturing areas and processes were contaminated. 
 Consequently, we needed to move cartridge assembly and manufacturing 
processes into a clean environment. I spear-headed the transition to clean manufacturing, 
with input from Dr. Angelika Niemz and Barbara Erwin. This entailed first identifying 
and securing lab space that had not yet been exposed to amplicon product. It was also 
important that this space have a locking door, so that we could control access to this area.  
After cleaning the new lab space, I then secured a laminar flow hood to be used 
for final cartridge manufacturing and assembly steps. This hood continually blows 
filtered air and maintains a clean environment inside the workspace. Once the hood was 
installed, the tools for all cartridge manufacturing processes needed to be replicated 
inside the hood. This required creating a second heated arbor press set-up for thermal 
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bonding, including all pouch dies, and each component was thoroughly cleaned with 
bleach solution prior to bringing it into the clean lab.  
Furthermore, all cartridge materials needed to be ordered to replace the materials 
we had been using in the contaminated lab areas. For the components that were directly 
assembled into the cartridges, such as plastic films and silicone foam, these items were 
carefully handled upon receipt and were directly moved into the clean room for storage to 
eliminate any possible amplicon exposure from contaminated lab areas. For components 
that required assembly and manipulation or testing prior to assembly into the cartridges, 
such as valves and septa, I developed a decontamination process. In previous studies, we 
demonstrated that dry-autoclaving effectively eliminates contamination. Therefore, all of 
these subassembly components were first manufactured and tested, then autoclaved and 
then brought directly into the clean lab for assembly into the cartridges. 
 After all of the components were replaced or decontaminated and all of the 
process tools were brought into the clean environment, I refined the manufacturing 
protocol for this environment. Once the process was optimized, I was able to manufacture 
clean initial cartridge prototypes and I demonstrated that these cartridges were not 
contaminated with amplicon product. In total, the transition to clean manufacturing 
required approximately one year until the first clean cartridges were fully-assembled and 
tested. 
 We have additionally transitioned the manufacturing of the refined cartridge 
prototype into this clean environment. As mentioned in Chapter 4, we are still optimizing 
this process. Our next step will be to design the manufacturing processes for the fully-
integrated cartridges in this clean lab.  
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